The Role of TRPA1 and Autonomic Imbalance in the Cardiac Response to Air Pollution by Kurhanewicz, Nicole
THE ROLE OF TRPA1 AND AUTONOMIC IMBALANCE IN THE CARDIAC 
RESPONSE TO AIR POLLUTION 
 
 
Nicole Anne Kurhanewicz 
 
 
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the 
Curriculum of Toxicology. 
 
 
 
 
Chapel Hill 
2016 
 
 
Approved by:  
Mehdi S. Hazari 
David Peden 
Daniel Costa 
Mark Zylka 
Brian C. Jensen 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2016 
Nicole Anne Kurhanewicz 
ALL RIGHTS RESERVED
iii 
ABSTRACT 
Nicole Anne Kurhanewicz: The Role of TRPA1 and Autonomic Imbalance in the Cardiac 
Response to Air Pollution. 
(Under the direction of Mehdi Hazari) 
 Exposure to air pollution has been shown to contribute to cardiovascular morbidity 
and mortality; this is especially true for certain susceptible subpopulations.  One mechanism 
linking air pollution and cardiovascular dysfunction involves perturbation of autonomic 
nervous system balance initiated by air pollution activation of airway sensory receptors. One 
such “sensor” is transient receptor potential A1 cation channel (TRPA1), which is expressed 
on airway afferent nerves and is known to be activated by certain ubiquitous air pollutants. 
Although this mechanism has classically been known to mediate certain reflexive respiratory 
responses, research suggests that a subset of cardiovascular responses are similarly produced. 
Thus my global hypothesis for this dissertation project is that autonomic imbalance during an 
acute exposure to air pollution, as indicated by heart rate variability (HRV), is mediated by 
TRPA1 and contributes to cardiac dysfunction. To test this, we first characterized the 
cardiovascular response of mice to acute particulate matter and ozone exposure. We then 
examined the cardiovascular impacts of inhaled acrolein, which is a TRPA1 agonist, in both 
wild-type and TRPA1 knockout mice. Lastly we determined if inhibition of either or both 
arms of the autonomic nervous system affected the acrolein-induced changes HRV. Co-
exposure to fine or ultrafine concentrated ambient particles and ozone produced ECG 
changes indicative of increased heterogeneity of repolarization, non-conducted p-wave 
arrhythmias, and decrements in cardiac mechanical function one day after exposure. 
iv 
Exposure to acrolein caused increases in HRV and bradyarrhythmia during exposure, as well 
as changes in cardiac mechanical function one day after exposure.  No exposure effects were 
observed in the TRPA1 knockout mouse.  Pharmacological inhibition of either or both arms 
of the autonomic nervous system demonstrated that acrolein exposure caused a biphasic 
response in which early sympathetic activation was followed by prolonged vagal dominance. 
These data suggest that air pollution causes autonomic imbalance and cardiac dysfunction 
through TRPA1. This research fills important gaps in our understanding of mechanisms 
underlying air pollution-induced cardiovascular dysfunction and will aid in risk assessment.  
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PREFACE 
 The first manuscript presented in this dissertation (Chapter 2) is a pre-copy-editing, 
author produced version of an article accepted for publication in Particle and Fibre 
Toxicology.  The definitive publisher-authorized version of this manuscript is available 
online at http://particleandfibretoxicology.biomedcentral.com/articles/10.1186/s12989-014-
0054-4 and is cited as follows: 
Kurhanewicz N, McIntosh-Kastrinsky R, Tong H, Walsh L, Farraj AK, Hazari MS. 
 Ozone co-exposure modifies cardiac responses to fine and ultrafine ambient 
 particulate matter in mice: concordance of electrocardiogram and mechanical 
 responses. Part Fibre Toxicol. 2014 Oct 16;11:54. 
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CHAPTER I:  INTRODUCTION 
Air Pollution and Public Health 
 The health impacts of outdoor air pollution largely became apparent following the 
industrial revolution during the 19th and 20th centuries, when urban centers began to rapidly 
expand with dense concentrations of both homes and industrial areas, providing ideal 
conditions for a range of public health concerns including chronic diseases and daily 
exposure to a variety of environmental toxicants.  During this time coal was widely used for 
the heating of homes and powering of factories and eventually resulted in some of the most 
deadly air pollution incidents in modern history.  The most widely cited of these is the 1952 
London Great Smog episode, where combustion-related emissions combined with a 
temperature inversion resulted in the excess deaths of an estimated 12,000 people (Bell & 
Davis 2001).  Pollution levels between December 5th-9th in 1952 London were 50-300% 
increased compared with previous years (5-19 times current regulatory standards).  The smog 
caused a sharp rise in hospital admission rates for both respiratory and cardiac diseases as 
well as pneumonia and influenza (Bell & Davis, 2001; Logan, 1956).  Two years earlier in 
1948 a similar episode had occurred in the U.S., in the small town of Donora, Pennsylvania 
where 20 of the town’s 14,000 residents died and over 7000 were hospitalized for 
cardiopulmonary injury or exacerbation of disease (Boyd, 1960).  Incidences of extreme air 
pollution like those observed in London and Donora were relatively uncommon, but were 
highly publicized.  They highlighted the public health consequences of ambient air pollution 
exposure and the growing need for monitoring and regulation of air pollution emissions.  
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 The first U.S. federal legislation addressing air pollution was the Air Pollution 
Control Act of 1955.  This act declared that air pollution posed a risk to public health, and 
authorized the surgeon general to work with state and local air pollution control agencies to 
recommend research programs and develop methods to reduce or eliminate ambient air 
pollution. However it maintained that individual states had the responsibility to establish 
their own air pollution controls.  The Air Pollution Control Act primarily provided funds for 
the federal government to research the sources and effects of air pollution (U.S. Congress 
1955).  In 1963 the Clean Air Act was passed, putting the onus of air pollution regulation on 
the federal government.  This act required the U.S. Department of Health to create and 
enforce automobile emissions standards.  The Clean Air Act of 1970 further expanded on the 
federal government’s ability to develop and enforce air pollution standards and controls from 
both stationary and mobile sources (US EPA 2016).  Also in 1970 the Environmental 
Protection Agency (EPA) was established for the purpose of consolidating federal research 
and monitoring programs pertaining to environmental and public heath, as well as developing 
and enforcing environmental pollution standards.  A major component of the 1970 Clean Air 
Act was the establishment of the National Ambient Air Quality Standards (NAAQS) which 
today designates six criteria air pollutants that are routinely and broadly monitored by the 
EPA.  These include ambient particulate matter (PM), ozone, carbon monoxide, sulfur 
dioxide, nitrogen dioxide, and lead (US EPA 2016). In addition to the six criteria air 
pollutants the EPA has identified and has regulatory standards for a list of 187 hazardous air 
pollutants (HAPs) which have the capacity to increase rates of cancer, produce other serious 
health impacts, or have significant environmental impacts (US EPA).  Even with more 
stringent air quality regulations in place, and greatly improved ambient air quality, the impact 
3 
of air pollution is an estimated 200,000 premature deaths per year in the U.S (Caiazzo et al. 
2013) and 3.7 million premature deaths per year worldwide (WHO, 2012), the vast majority 
arising from cardiopulmonary injury or disease.  
 Present day ambient air pollution comprises a diverse mixture of substances including 
particulate patter (PM), gases, organic compounds, and toxic metals (Brook et al. 2010; 
Verrier et al. 2002). PM exposure in particular has been linked with a variety of adverse 
cardiovascular outcomes including myocardial infarction, stroke, arrhythmia, and 
exacerbation of heart failure. However the 2010 American Heart Association scientific 
statement pointed out that, “Although PM2.5 mass has rightfully attracted attention as a 
target for regulation and epidemiological study, more than 98% of the air pollutant mass in 
the mixture we breathe in urban settings is from gases or vapor phase compounds such as 
CO, volatile organic carbons (OCs), NO2 , NO [nitric oxide], O3 , and SO2 .” (Brook et al. 
2010). Each of these may have independent effects or combined effects with co-pollutants.  
Aldehydes, a class of volatile organic compounds, have attracted interest since the earliest 
days of air pollution research due to their ubiquitous and highly irritating nature (Quade R . 
Stahl 1969). 
 
Acrolein 
 Acrolein is a common constituent of ambient air pollution and a prototypical airway 
irritant. It is a small, highly reactive, unsaturated aldehyde produced by the combustion of 
organic compounds. Because acrolein is so reactive it can bind nucleophiles such as 
glutathione as well as react with cysteine, histidine and lysine residues to form protein 
adducts (Kehrer & Biswal 2000).  In this way acrolein exposure can produce structural 
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damage or functional changes which may result in cytotoxicity, oxidative stress and 
inflammation, as well as react with non-specific binding sites on dermal and airway 
nociceptive receptor channels. Humans are primarily exposed to acrolein via contact with 
cigarette smoke, automobile exhaust, structural and wildfire smoke, and some industrial 
processes including the burning of wood or coal (CDC-ASTDR 2007; Ghilarducci & 
Tjeerdema 1995).  In 1999 estimated ambient acrolein concentrations ranged from a national 
average of 0.033 ppm to a high of 0.19 ppm (Woodruff et al. 2007; Walsh 2008).  Cigarette 
smoke contains up to 90 ppm acrolein, and acrolein levels in side-stream tobacco smoke have 
been measured as high as 10 ppm (Esterbauer et al. 1991).  The U.S. EPA currently classifies 
acrolein as a HAP and determined that it represents the leading non-cancer hazard in ambient 
air pollution causing adverse respiratory health effects (Ris 2007). Acrolein is known to 
primarily impact the upper airway, with nasal mucosa representing the most sensitive target 
of inhalation exposure (Shusterman 2012; CDC-ASTDR 2007), although the effects can 
extend deeper into the respiratory tract as exposure levels increase (CDC-ASTDR 2007).  
Inhalation of acrolein induces a variety of respiratory effects including nose and throat 
irritation (Beauchamp, Andjelkovich, Kligerman, Morgan, & Heck, 1985; Sim & Pattle, 
1957), apnea (Lee et al. 1992), pulmonary edema (Hales et al. 1989; Kutzman et al. 1985), 
asthma like symptoms such as increased bronchial responsiveness and respiratory distress 
(Ben-Jebria et al. 1994; Bein & Leikauf 2011), and has been shown to exacerbate existing 
asthma (Leikauf et al. 1989). Acrolein exposure has also been shown to produce 
cardiovascular effects as well (DeJarnett et al. 2014) including cytotoxicity in pulmonary 
artery endothelial cells and cardiac fibroblasts in vitro (Kachel & Martin 1994; Toraason et 
al. 1989).  In vivo animal studies have also demonstrated that acute exposure primarily 
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produces short-lived effects including bradycardia (Lee et al. 1992), while chronic exposure 
to inhaled acrolein can produce dilated cardiomyopathy (Ismahil et al. 2011) and contributes 
to the development of thromboses (Sithu et al. 2010; O’Toole et al. 2009).  
 
Mechanisms Linking Pulmonary Exposure to Cardiovascular Effects 
 Historically, airway and pulmonary sites were believed to be the primary target of air 
pollution.  However, now systemic effects including those on the central nervous system, 
metabolism and cardiovascular systems have been drawing increasing attention over the last 
15 to 20 years (Calderón-Garcidueñas et al. 2007; Mills et al. 2009; Kodavanti 2015; Wagner 
et al. 2014).  In fact, a growing body of evidence demonstrates that elevations in ambient air 
pollution, particularly PM, results in greater risks for cardiovascular related mortality than for 
any other causes including respiratory disease (Brook et al. 2010).   
 Biological mechanisms linking air pollution with adverse cardiovascular outcomes 
involve both the direct effects of pollutants on cardiovascular tissues and indirect effects 
mediated through more general pathways including oxidative stress and inflammation.  
Putative mechanism include 1.) Systemic inflammation and oxidative stress, 2.) The direct 
effect of agents which may readily pass through the pulmonary epithelium into the blood, 
and 3.) Perturbation of systemic autonomic nervous system balance by air-pollutant 
interactions with airway sensory receptors (Simkhovich et al. 2008; Brook et al. 2004; Brook 
et al. 2010). 
 Episodes of chronic air pollution exposure can induce sustained local oxidative stress 
and pulmonary release of pro-inflammatory mediators including cytokines, activated immune 
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cells, as well as vasoactive molecules (Grunig et al. 2014).  Additionally, sustained airway 
inflammation sensitizes airway sensory nerves, provoking the further release of 
proinflammatory neurotransmitters and enhancing the proinflammatory state of the airways 
(Zholos 2015; Lee & Widdicombe 2001).  Moreover prolonged periods of oxidative stress 
can deplete the airway antioxidant capacity, impairing a primary defense mechanism of the 
airway mucosa and producing further tissue damage (Domej et al. 2014).  Over time 
profound airway inflammation may contribute to a state of systemic inflammation which can 
disrupt hemostatic pathways and impair vascular function.  In fact, the primary adverse 
cardiovascular outcome linked with this mechanism is the development of atherosclerosis as 
well as its sequelae (Park et al. 2010; Gill et al.; Provost et al. 2015).   
 Constituents of air pollution capable of crossing the pulmonary epithelium include 
gases, soluble constituents of particulate matter such as organic compounds or metals, and 
possibly ultra-fine particles (Brook 2008).  Since oxygenated blood leaving the lungs makes 
its first pass through the heart before entering systemic circulation the largest effect of 
translocated constituents of air pollution would be on the myocardium itself (Nemmar et al. 
2002; Nemmar et al. 2004).   
 In addition, the airways are richly innervated with sensory nerves that react to 
irritating or noxious stimuli and initiate protective physiological responses (Widdicombe 
2001; Lee & Pisarri 2001; Coleridge et al. 1983).  These responses are mediated by reflexive 
changes in autonomic nervous system regulation of cardiopulmonary function which 
originate in the brainstem, as well as release of neurotransmitters which provoke local 
immune responses (Perez et al. 2015; Lee & Pisarri 2001; Bessac & Jordt 2010).  In this way 
activation of airway sensory nerves by air pollutants can transiently alter autonomic nervous 
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system balance and cardiovascular function.  Under normal physiological conditions, this 
system ensures that the body maintains its function (e.g. perfusion of tissues, oxygenation, 
anti-oxidant potential) during changing conditions or even certain extremes.  Exposure to an 
environmental stressor can result in perturbation of internal homeostatic mechanisms 
including autonomic nervous system controls such that a subsequent trigger might 
significantly increase the risk of adverse cardiovascular events like arrhythmia (Brook et al. 
2004). In individuals with underlying cardiovascular or pulmonary disease, the disruption of 
autonomic balance may actually result in cardiovascular morbidity or mortality given they 
already have impaired cardiopulmonary compensatory capacity (Goldberg et al. 2001; 
Routledge et al. 2003; Brook et al. 2004). 
 
Airway Sensory Nerves 
 The challenge in understanding the cardiovascular risk attributable to short-term air 
pollution exposure lies in linking respiratory exposure and cardiovascular response by a 
mechanism capable of producing immediate and reversible effects, which are often latent.  
Historically adverse cardiovascular effects following acute exposure to air pollution have 
been readily observable in populations with underlying cardiovascular disease (Franchini & 
Mannucci 2007), however cohorts of healthy young individuals have also demonstrated a 
shift towards a higher risk for adverse cardiovascular events with acute exposure to air 
pollution (Shields et al. 2013; Allen et al. 2011; Brook et al. 2004), indicating a general 
mechanism shared by both populations.  Activation of neural pathways through airway 
chemosensors and subsequent disruption of autonomic balance may explain not only the 
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worsening of existing disease but also sudden impairment in people who are seemingly 
healthy. 
 As such, chemosensory nerve endings in the airway mucosa are one of the first lines 
of defense against noxious chemicals and stimuli. Activation of these “sensors” trigger 
crucial protective reflexive responses such as coughing, sneezing and the sensation of 
irritation and pain (Widdicombe 2001; Bessac & Jordt 2008; Carr & Undem 2003).  The 
respiratory system, from the nose into the deep lung, is innervated by multiple nerve types 
which have the ability to respond to a variety of stimuli including irritating molecules, cold, 
changes in osmolality, and changes in lung inflation (Perez et al. 2015; Bessac & Jordt 2008).   
The cell bodies of airway sensory nerve fibers reside in the jugular and nodose ganglia of the 
vagus nerve and project to the nucleus tractus solitarius (NTS) in the medulla.  Afferent 
activity arising from airway sensory nerves is transmitted into the central nervous system (i.e. 
brainstem) where the signal is modulated and then eventually results in efferent signaling via 
autonomic nerves to the viscera (Carr & Undem 2003; Bonham et al. 2006). As mentioned 
above, this homeostatic system functions tonically on a breath-by-breath basis affecting 
respiratory and cardiovascular activity (e.g. respiratory sinus arrhythmia) but is also then 
immediately altered in the event of exposure.  
 Airway sensory nerve fibers are characterized by 3 primary receptor types including 
C-fibers, rapidly adapting pulmonary receptors (RARs), and slowly adapting pulmonary 
receptors (SARs) (Kubin et al. 2006; Perez et al. 2015; Widdicombe 2001). While both 
RARs and C-fibers can be broadly described as irritant sensors which mediate reflexive 
pulmonary responses, SARs are stretch receptors located in the airway smooth muscle of the 
lower airways which respond to inflation of the lungs (Widdicombe 2001). The homeostatic 
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role of these sensory fibers, as detailed above, is the modulation of HR and cardiac output in 
response to variation in breathing patterns that are both normal and abnormal (i.e. occurring 
due to irritation).  This includes respiratory sinus arrhythmia (RSA), which is heart rate 
variability that occurs in synchrony with respiration and causes heart rate to increase during 
inspiration and decrease during expiration (Perez et al. 2015; Widdicombe 2001).  Yet, in 
terms of air pollution health effects, the most important sensory fibers appear to be the C-
fibers, which are characterized by their distinct sensitivity to both exogenous chemical 
stimuli including sulfur dioxide, acids, cigarette smoke, ozone, acrolein, ammonia and 
particulate matter, as well as endogenous inflammatory mediators (Kollarik et al. 2010) and 
which morphologic studies have demonstrated to be seventy-five percent of vagal afferent 
nerve fibers arising from the respiratory tract (Agostoni et al. 1957). 
 C-fibers were first identified by Coleridge and Coleridge in 1984 (Coleridge & 
Coleridge 1984) and since then they have become recognized as important regulators of 
cardiopulmonary function under both normal and abnormal physiologic conditions.  General 
anatomical and functional features of C-fibers are well conserved across most species in 
which they have been studied including human, monkey, dog, cat, rabbit, guinea pig, rat, 
mouse and (Canning & Chou 2009). They are located throughout the respiratory tract 
including the nose, larynx, trachea, bronchi, and alveoli (Widdicombe 2001); they are usually 
found just below the airway epithelium but can occasionally be located deeper in the mucosa 
adjacent to arterioles (Widdicombe 2001). Responses to C-fiber activation are mediated 
through both central reflex pathways and via local release of neuropeptides (Lee & Pisarri 
2001).  Intense, rapid C-fiber activation produced by a bolus injection of established C-fiber 
activators such as capsaicin cause reflex apnea often followed by rapid shallow breathing 
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(Coleridge & Coleridge 1984), however more moderate levels of pulmonary fiber discharge, 
akin to the tonic level of pulmonary C-fiber activation physiologically present without robust 
exogenous stimulation, produces an increase in respiratory rate and a decrease in tidal 
volume (Lee & Pisarri 2001).  C-fiber activation also causes reflex bronchoconstriction and 
airway mucus secretion (Lee & Pisarri 2001). Cardiovascular reflex responses to C-fiber 
activation include bradycardia along with systemic and pulmonary hypotension (Perez et al. 
2015; Lee & Pisarri 2001) all of which are primarily mediated through enhanced vagal 
modulation through the brainstem (Lee et al. 1992). On the other hand, local effects in the 
airways are mediated via the release of neuropeptides including substance p, neurokinin A 
and calcitonin gene related protein neuropeptides (Saria et al. 1988); these include 
bronchoconstriction and the development of pulmonary edema, and induction of 
neuroinflammation (Lee & Pisarri 2001; Kollarik et al. 2010).   
 A common feature of all responses to C-fiber activation is that they act to prevent 
noxious stimuli, or at the very least limit its impact (Bessac & Jordt 2010; Lee et al. 1992; 
Coleridge & Coleridge 1984).  Reflexive bronchoconstriction and decreased tidal volume 
reduce inhalation of the irritant into the lung while enhanced mucus secretion protects the 
airway mucosa.  Increased breathing rate may aid in the removal of irritants from the deep 
lung, and decrease of heart rate reduces oxygen demands until normal physiological function 
can be resumed.  Despite their robust response to noxious stimuli bronchopulmonary C-fibers 
are generally quiescent in healthy airways (Canning & Chou 2009; Kollarik et al. 2010).  
However under abnormal physiological conditions, particularly with persistent airway 
inflammation C-fibers become sensitized and produce enhanced responses (Lee & Pisarri 
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2001).  Enhanced C-fiber excitability is believed to play a role in the pathophysiology of 
number of chronic airway diseases including asthma and COPD. 
 
TRPA1 
 Transient receptor potential ion channels (TRP) are expressed throughout the upper 
and lower airways on trigeminal and vagal afferent C-fibers.  In 1997 successful cloning of 
the TRP capsaicin, or vanilloid receptor, TRPV1 was reported (Caterina et al. 1997) and 
immunohistochemical studies confirmed the presence of TRPV1 on the airway sensory fibers 
in the nasal mucosa, trachea, bronchi and alveoli (Bessac & Jordt 2008).  These discoveries 
started a new wave of chemosensory research with hundreds of studies dedicated to the 
identification of TRP family members, their pharmacology, structure, function, and 
physiological role in chemosensation and nociception in the airways (Eid & Cortright 2009).  
Initially identified in 1999 as ANKTM1, a theoretical protein expressed in cultured 
fibroblasts (Jaquemar et al. 1999), TRP ankyrin 1 (TRPA1) was rediscovered in 2003 as a 
cold-activated TRP channel found in a subset of nociceptive sensory nerve fibers where it is 
co-expressed with TRPV1 (Story et al. 2003).  
 TRPV1 and A1 are both cation-permeable channels that act as chemical sensors and 
react to a variety of exogenous and endogenous compounds, however activation of these 
channels produce sensations with divergent effects (Wetsel 2011). TRPV1 is known to be a 
key mediator of thermal and pain sensation.  Activation by capsaicin, a well described 
agonist, produces a burning sensation.  TRPV1 is also activated by painfully hot thermal 
stimuli (Story 2006; Caterina et al. 1997). Conversely, TRPA1 is activated by painfully cold 
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stimuli, but also displays activation by a variety of noxious compounds, many of which 
evoke cold and pain sensations (Story et al. 2003). 
 TRPA1 is the only member of the TRPA subset expressed in mammals.  It is 
expressed in 20-35% of sensory neurons (Bessac & Jordt 2008). Structurally it is 
characterized by a large number of ankyrin repeats on the long cytoplasmic N-terminal 
domain.  Four identical TRPA1 subunits combine to form the functional channel (Caterina 
2007), however recently there has been evidence to suggest functional TRPA1:TRPV1 
heteromers (Fischer et al. 2014).  Whether or not TRPA1 regularly combines with TRPV1 to 
form heteromers, it has been repeatedly demonstrated that TRPA1 and TRPV1 channels 
interact both under normal physiological conditions and in disease states (Bessac & Jordt 
2008; Staruschenko et al. 2010; Salas et al. 2009).  Activation of TRPA1 is thought to occur 
primarily via covalent modification of cystine residues on the N-terminal domain (Hinman et 
al. 2006; Macpherson et al. 2007; Caterina 2007).  Activation via a non-specific mechanism 
such as cysteine modification allows for the wide variety of known TRPA1 activators 
including structurally diverse substances found in industrial chemicals, environmental 
exposures, natural products, pharmaceuticals and endogenous molecules, particularly 
oxidizing agents and electrophiles (Bessac et al. 2008).  As many TRPA1 agonists can react 
with thiols, antioxidant levels in the airways, particularly glutathione, can modulate the 
efficacy of TRPA1 activating airway irritants (Bessac et al. 2008; Lee & Widdicombe 2001).  
Poor antioxidant capacity or complete depletion allows for increasing numbers of covalent 
cysteine modifications with every breath of inhaled agonist. In this way irritant-induced 
TRPA1 activity may be heightened, even in low-level, sub-chronic exposures scenarios.   
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 In 2006 a TRPA1 knockout mouse was developed (Kwan et al. 2006).  These mice 
were generated by deleting exons that code for the pore domain of the ion channel, rendering 
the channels non-functional.  Constitutive knockout animals were backcrossed to the 
C57BL/6J line for over 10 generations to produce a TRPA1 knockout animal that is 
essentially in the C57BL/6K genetic background. These mice demonstrate no behavioral 
responses to topical application of mustard oil, cold (0 C), or punctate stimuli. They do 
however demonstrate normal startle reflex to loud noise, a normal sense of balance, and 
normal auditory brainstem response (Kwan et al. 2006).  It has also been reported that 
TRPA1 knockout mice not respond to inhaled oxidants but do respond predictably to the 
non-TRPA1 specific C-fiber irritant acetic acid (Bessac et al. 2008).  Implying that the 
model’s response to non-TRPA1-activating exposure types is not impaired. 
 TRPA1 has been investigated thoroughly in its role as a nociceptor in dermal pain 
pathways, particularly with regard to cold or noxious chemical sensation, and 
neuroinflammation (Bautista et al. 2006; Bodkin & Brain 2011; Guimaraes & Jordt 2007).  
Because of this TRPA1 presents a ready target in the development of anti-inflammatory 
drugs and analgesics (Brederson et al. 2013; Chen et al. 2011).   It is also fairly well 
understood as an airway sensor (Bautista et al. 2006) and has been suggested previously as a 
mediator of cardiovascular effects via reflex modulation of autonomic reflex function 
(Hooper et al. 2015; Pozsgai et al. 2010). More recently a direct role for TRPA1 in 
cardiovascular function has been investigated and found that TRPA1 expressed in the 
vasculature may act as a cold and/or oxidant sensor there as well as contribute to 
autonomically mediated vasodilatory responses (Aubdool et al. 2014; Pozsgai et al. 2010; 
Bodkin et al. 2014; Earley 2012; Graepel et al. 2011). 
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 Due to its presence on pulmonary C-fibers known to initiate autonomic reflex arcs 
upon activation, its propensity toward activation by a large variety of substances commonly 
found in ambient air pollution including acrolein, and the availability of a knockout mouse 
model, TRPA1 represents a prime target for research as a mediator of airway irritant induced 
cardiovascular dysfunction via the perturbation of autonomic balance and homeostasis. 
 
Autonomic Control of the Heart 
 The autonomic nervous system is the division of the peripheral nervous system 
responsible for control of bodily functions not consciously directed, such as breathing, the 
heartbeat, and digestive processes. It is split into two branches: sympathetic and 
parasympathetic.  In situations where an organism encounters a stressor the sympathetic 
nervous system dominates; heart rate and respiration increase, blood pressure increases, and 
blood is redirected to muscles and organs important to the “fight or flight” response and 
away from non-essential areas such as the gut.  When the stressor is removed and the 
organism is returning to a resting state the parasympathetic nervous system dominates; heart 
rate and respiration slow, and activity in the gut recommences, hence the phrase “rest and 
digest”.  While the actions of the sympathetic and parasympathetic branches of the 
autonomic nervous system do oppose each other to some extent, it is not a reciprocal system: 
when one rises the other does not automatically fall.  There can be co-activation or co-
depression or any degree of activation of either branch simultaneously.  Furthermore the 
actions of either branch of the autonomic nervous system are not systemically uniform; even 
in a resting state different tissues and organ systems are variably affected by either 
sympathetic or parasympathetic modulation. For example, in humans, control of heart rate is 
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primarily parasympathetically dominated while the vasculature is controlled by the 
sympathetic branch. Overall the important aspect of the relationship between the actions of 
the sympathetic and parasympathetic nervous systems is that they are coordinated such that 
cardiovascular homeostasis is maintained. 
 Like all vital bodily systems the cardiovascular system is dynamic, reacting moment 
to moment to both internal and environmental stimuli and adjusting physiological parameters 
such as heart rate, contractility, and blood pressure to ensure sufficient systemic perfusion 
and meet the ever changing metabolic demands of the body. The regulation of this complex 
balancing act is traditionally described in terms of homeostasis. This word comes from the 
Greek homeo (similar) and stasis (steady) and refers to the body's ability to return toward a 
relatively stable internal set point, even while continually subjected to external changes. An 
important aspect of cardiovascular homeostasis is heart rate.  Heart rate is normally 
determined by periodic depolarization of the sinoatrial (SA) node, the frequency of which is 
primarily modulated by both the sympathetic and parasympathetic branches of the autonomic 
nervous system.  Additionally, physiological feedback from the intrinsic cardiac nervous 
system, autonomic reflexes including baroreflex, chemoreflex and even irritant reflexes 
originating in the airways, thermal regulation and respiration can all contribute to beat by 
beat adjustments to heart rate (Figure 1.) (Perez et al. 2015; Perini & Veicsteinas 2003; 
Purves et al. 2001).  This dynamic nature of the cardiovascular system directs our attention 
not only to average or baseline heart rate values, which can be regarded as the reference set 
point, but also to perturbations of this average as various studies have demonstrated these 
fluctuations are indeed much more than noise. As such, the study of heart rate variability 
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(HRV) represents a valuable source of information that can provide insight into the 
mechanisms of cardiovascular control (Appel et al. 1989).  
 
Heart Rate Variability  
 HRV has become an 
increasingly popular 
endpoint for analysis of 
autonomic function, 
because of its non-invasive 
nature and because of its 
applicability in both humans 
and animal models 
including rodents (Farraj, 
Hazari & Cascio 2011; 
Rowan et al. 2007; Thireau 
et al. 2008). Since a simple 
ECG readout and HR 
analysis is all that is required for HRV calculation it is now used commonly as a prognostic 
indicator in clinical settings (Anon 1996) and in commercially available software used in the 
fields of psychology and sports medicine.  Two broad approaches to calculating HRV are 
time and frequency domain analysis.  Time domain analysis are basic statistical analyses of 
normalized RR intervals: the standard deviation of subsequent normalized RR intervals 
(SDNN) and the root mean square of the standard deviation of subsequent normalized RR 
Perez et al., 2015. Cardiovasc Toxicol. 2015 
Jan;15(1):69-78 
Figure 1. Multiple autonomic and neural pathways 
contribute to the body’s response to stimuli 
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intervals (RMSSD).  SDNN represents all cyclic components contributing to variability, 
therefore representing an overall measure of HRV while RMSSD more specifically correlates 
with parasympathetic modulation (Rowan et al. 2007).  HRV can also be calculated via 
frequency domain analysis whereby high or low frequency bands are assigned and power 
spectral density analysis is performed using a fast Fourier transformation.  This provides 
basic information regarding the power across a low frequency (LF) vs high frequency (HF) 
bands.  LF power is believed to represent a mixture of sympathetic and parasympathetic 
components as well as inputs from mechanisms governing blood pressure regulation (Reyes 
del Paso et al. 2013; Goldstein et al. 2011; Rahman et al. 2011; Moak et al. 2007) while HF 
power again correlates with parasympathetic modulation but likely also represents inputs 
from changes in cyclic ventilatory patterns (Billman 2013; Reyes del Paso et al. 2013; Chess 
et al. 1975; Piccirillo et al. 2009; Heathers 2014).   
 Changes in HRV have been observed in various stressful circumstances including 
during exercise (Perini & Veicsteinas 2003; Baumert et al. 2006), in response to fearful 
stimuli (Liu et al. 2014) and in response to perceived stress (Dishman et al. 2000).  Both 
acute and chronic stress have been shown to induce an overall decrease in HRV whereby 
some combination of increased sympathetic modulation and vagal withdrawal occurs (Liu et 
al. 2014; Schubert et al. 2009).  With repeated stressful stimulus however habituation is 
observed, attenuating the intensity and duration of the HRV response (Liu et al. 2014). 
 Under normal conditions heart rate, which is governed by a variety of regulatory 
mechanisms (e.g. ANS, pre-load, after-load, circulating peptides), displays robust R-R 
interval variability which allows the heart to effectively adapt to external stressors and 
maintain homeostasis.  Thus, a shift towards stronger HR regularity may indicate decreased 
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responsiveness to both external stimuli and internal control mechanisms (Rahman et al. 2002; 
Lipsitz & Goldberger 1992; Pincus 1994; Schubert et al. 2009), representing a risk for 
adverse cardiovascular events due to reduced compensatory capacity. In fact it has been 
demonstrated that decreased HRV occurs over a broad range of cardiovascular illnesses and 
injury (Gang & Malik 2003; Thayer et al. 2010; Tsuji et al. 1996).  Reduced HRV has been 
associated with increased risk of fatal arrhythmias, heart attack and stroke, particularly in 
populations with existing cardiovascular disease (Ponikowski et al. 1997; Valkama et al. 
1995; Kop et al. 2001).  Significantly, low HRV has also been associated with adverse 
cardiovascular events in apparently healthy populations as well (Hillebrand et al. 2013).  
Although classically low HRV has been accepted as an indicator of heightened 
cardiovascular risk, elevated HRV has also been linked to adverse cardiovascular outcomes 
(Stein et al. 2005; Amar et al. 2003; Schwartz et al. 2011; Eguchi et al. 2010).  Specifically, 
increased HRV, indicating enhanced vagal modulation, has been implicated in a group of 
heart rhythm disorders that involve impaired SA node function termed sick sinus syndrome 
(SSS) which is characterized by severe sinus bradycardia, often with alternating tachycardia, 
SA node arrest or block (Keller & Lemberg 2006; Brignole 2002; Adán & Crown 2003; 
Gladuli et al. 2011; Semelka et al. 2013).  Symptoms can occur in intermittent periods or 
chronically, and depending on severity of disease may produce dizziness and syncope.  There 
are a number of pathophysiologies which could produce SSS.  It is often idiopathic and the 
result of degenerative diseases affecting nodal tissue (Keller & Lemberg 2006).  Conversely, 
sinus node dysfunction is also associated with diseases affecting the autonomic nervous 
system (Brignole 2002; Semelka et al. 2013), thus abnormal parasympathetic modulation and 
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resulting ECG features may be originating in the central nervous system (rather than 
degeneration of SA node itself).   
 Ambient air pollution, depending on its physical and chemical composition, has the 
capacity to act as a potent chemical stressor and has been shown to elicit cardiac autonomic 
responses (Arjomandi et al. 2015; Gold et al. 2000; Pope et al. 1999; Godleski et al. 2000). 
While decreased HRV is a commonly accepted indicator of heightened cardiovascular risk 
following air pollution exposure in humans (Gold et al. 2000), increases HRV have also been 
demonstrated (Chen & Hwang 2005; Bortkiewicz et al. 2014). For example, increased 
RMSSD has been shown to be associated with elevated risk of air pollution-induced 
arrhythmia (Davoodi et al. 2010) In fact our lab has consistently shown that exposure to 
different types of air pollutants such as residual oil fly ash (Farraj, Hazari, Haykal-Coates, et 
al. 2011; Carll et al. 2015) diesel exhaust (Hazari et al. 2011; Carll et al. 2013), ozone (Farraj 
et al. 2012) and acrolein (Hazari et al. 2014) all lead to an increase in HRV in rodent models. 
Considering that parasympathetic modulation is a well-characterized reflex response to 
airway sensory activation (Lee & Pisarri 2001; Alarie 1973; Bessac & Jordt 2010) these 
results are not surprising.  
 Interestingly there is also evidence that abnormal variation in heart rate and heart rate 
variability as seen with enhanced vagal tone (and sick sinus syndrome) has a destabilizing 
effect on the atrial tissue (Shetty & Scott 2015) which can contribute to the 
pathophysiological progression of cardiac disease or injury.   So, when we are considering 
sensitive subpopulations, such as those with underlying cardiac disease, the capability of air 
pollution to induce these types of changes not only increases their risk for adverse cardiac 
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events but through this mechanism can exacerbate and may also physically worsen their 
condition. 
 Taken together it is apparent that any perturbation of homeostatic balance has the 
potential to increase risk of adverse cardiovascular events if the shift is drastic enough or 
combined with other perturbation causing stimuli. In that sense, HRV changes in either 
direction might indicate that sympathetic and parasympathetic nervous systems are not 
properly coordinating to provide an appropriate heart rate response to environmental 
stressors or internal cues. 
 
TRPA1: Connecting the Airways and Heart through Central Neural Circuits 
 Linking all these processes, the activation of TRPA1, neuro-modulation in the 
brainstem and autonomic effects, including those on the heart, is substance P, a tachykinin 
neuropeptide involved in numerous neuro-modulatory processes.  Activation of TRPA1 
causes a release of Substance P in the airways (Saria et al. 1988), which produces its own set 
of local effects, while transmission of the signal via afferent airway sensory C-fibers to the 
NTS releases substance P there as well (Morilak et al. 1988).  This secondary release of 
substance P in the NTS upon activation of airway C-fibers has been shown to modulate 
efferent signaling and contribute to changes in autonomic nervous system function.  This 
connection was previously described with respect to respiratory responses to airway irritants 
whereby activation of airway sensory nerves by side-stream cigarette smoke produced 
excitability of lung sensory afferent fibers, this in turn caused substance P release and 
increased excitability at the NTS synapses and finally enhanced respiratory reflex responses 
(Mutoh, Joad, et al. 2000; Bonham et al. 2001).  Furthermore it has been demonstrated that 
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the NTS plays a critical role in the integration of a wide range of peripherally initiated 
sensory information in addition to airway receptor activation, including baroreflex and 
chemoreflex receptors activity, as well as the central control of cardiovascular function 
(Lawrence & Jarrott 1996; Potts).  Thus it is reasonable to assert that cardiovascular and 
respiratory reflex responses to C-fiber activation are similarly mediated via substance P 
release in the NTS.  It is this arc of neural activity (Figure 2.) that may determine the final 
cardiovascular outcome. The key question as research moves forward in this field is how 
long do these effects persist and how can the key mediators be identified in those most 
susceptible? With regards to the latter, I hypothesize that alteration of homeostatic 
mechanisms like autonomic control by air pollution exposure, however short-lived, will alter 
those regulatory processes that employ autonomic efferent signals to maintain a given 
function. For example, we have already demonstrated that acrolein exposure desensitizes the 
baroreflex response by blunting the sympathetic outflow to the heart (Hazari et al. 2014). 
Thus, it may not necessarily be the exposure that directly causes the adverse response but 
rather some other subsequent event that further “pushes” the body out of balance. 
 
Summary 
 Although air quality has consistently improved over the last few decades, ~40% of 
the US population still lives in areas that meet or exceed National Ambient Air Quality 
Standards (NAAQS) for at least one primary air pollutant as established by the U.S. 
Environmental Protection Agency (EPA)(Anon n.d.).  Center for Disease Control (CDC) 
reports additionally state that ~11.5% of the adult, non-institutionalized population in the 
U.S. has a diagnosed cardiovascular disease (CDC 2016).  Recent studies demonstrating the 
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relationship between high air-pollution days and a significant increase in hospital visits for 
serious cardiovascular events, particularly in populations with existing cardiovascular 
disease, highlight the need for a more complete understanding of the mechanisms underlying 
this relationship (Colais et al. 2012; Dockery et al. 1993; Pope et al. 2004). On the other 
hand, when air pollution levels are not exceedingly high, or in the case of acute exposure, it 
is assumed that the effects are minimal or even non-existent, especially when clinically 
observable symptoms are lacking. As such, subtle effects may go unnoticed but nonetheless 
represent a serious risk (Hazari et al. 2011).  At these lower and seemingly benign air 
pollution concentrations or durations, and in the absence of host perception of an effect, it 
would be suitable to examine the role of airway sensory nerves which not only “sense” the 
toxicant but also cause internal homeostatic changes that may predispose to cardiopulmonary 
dysfunction.  Airway sensors, particularly TRPA1, located on airway C-fibers have been 
demonstrated to play a major role in airway reflex responses, and have been suggested as 
possible mediators of some cardiovascular responses as well (Hazari et al. 2011; Jones et al. 
1995; Lee 2010; Wang et al. 2000)(Lee 2010; Wang et al. 2000; Jones et al. 1995; Hazari et 
al. 2011).  The studies presented herein explore TRPA1 as a major sensor of airway irritant 
pollutants and address the mechanisms through which it produces autonomic imbalance and 
adverse cardiovascular effects following exposure to air pollution.  
 
Purpose of Research and Global Hypothesis 
 Although acute exposure to air pollution has been firmly associated with an increased 
risk of adverse cardiovascular events, the precise mechanisms of toxicity may not be easy to 
identify given they are quite numerous and often co-exist. Time-series studies indicate that 
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the risk of cardiac events and arrhythmias increase significantly in the hours and days 
immediately following air pollution exposure. Yet, epidemiological studies by their nature 
cannot quantify the physiological response in humans during exposure; this is crucial 
information in air pollution toxicology because it can shed light on the early initiating events 
resulting from exposure which influence and direct subsequent pathways in the hours and 
days following exposure.  Although numerous biological pathways have been proposed by 
which air pollution may cause cardiovascular events, airway sensory activation may be the 
most relevant when considering the short-term, reversible, and often latent effects of an acute 
exposure. Toxic air pollutants, including particulate matter, acrolein, and ozone stimulate 
sensory nerves in the airways causing several well-described ventilatory and pulmonary 
effects, however the cardiovascular responses have not been sufficiently characterized.  
 A subset of these responses are known to be mediated by the transient receptor 
potential cation A1 (TRPA1) channels present on chemosensitive C-fibers. Thus, TRPA1 
represents a likely candidate as an initiator of air-pollution induced cardiovascular 
dysfunction. The mechanism through which airway sensory nerve activation perturbs 
cardiopulmonary function has been broadly described as occurring through modulation of 
autonomic nervous system function, however specific changes in measures of autonomic 
modulation have not yet been clearly characterized or linked with changes in 
cardiopulmonary function. Thus my global hypothesis for this dissertation is that cardiac 
dysfunction following a single acute exposure to air pollution is in part driven by airway 
TRPA1 activation and that autonomic imbalance initiated during exposure may contribute to 
the changes observed up to one day after exposure (Figure 2.).  The primary purpose of this 
research is to better understand the specific autonomic mechanisms underlying air pollution 
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induced cardiotoxicity, which will contribute relevant data to improve assessments of risk, as 
well as identify potentially sensitive subpopulations and define windows of heightened 
susceptibility following exposure.  
 
In order to address this hypothesis the following specific aims were established:  
 Aim 1) Characterize decrements in cardiac mechanical and electrical function 
observed in the mouse with exposure to air pollution.  The aim of this study was to 
determine the independent effects of fine (FCAPs) and ultrafine (UFCAPs) concentrated 
ambient particles on cardiac function in C57BL/6 mice, and explore whether ozone (O3) co-
exposure would alter the response. These experiments examined a wide range of cardiac 
endpoints including electrical function and rhythm, which were assessed via 
electrocardiogram (ECG) analysis, mechanical properties and post-ischemia recovery, which 
were measured using a Langendorff technique, as well as biochemical indicators of cardiac 
Figure 2.  Acute air pollution exposure produces cardiovascular dysfunction via 
autonomic imbalance mediated by TRPA1 
Adapted from original image © 2013 Pearson Education 
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toxicity. This work fills a unique gap in the existing literature as few studies, if any, have 
examined the effects of simultaneous particulate matter (PM) and O3 exposure on both ECG 
and mechanical function (e.g. contractility) of the heart.  Risk assessments of air pollution 
health effects have become increasingly challenging given the complexity of present-day air 
pollution mixtures.  Previous data suggests that PM size determines the physiological impact 
with fine PM causing primarily pulmonary effects and ultrafine PM altering cardiac function. 
However, air pollution is a mixture of not only PM, but also gaseous irritants, vapors, and 
biological substances.  Thus when examining the effects of a given pollutant, the influence of 
other components must be considered, and so studies are needed to determine whether the 
physiological and biochemical responses to multipollutant exposures represent the simple 
additive effects of the pollutants, their synergism or antagonism. One particularly relevant 
interaction is that of PM and the ubiquitous gaseous co-pollutant O3. Thus, we hypothesized 
(1) that inhalation of either fine (FCAPs) or ultrafine CAPs (UFCAPs) would cause cardiac 
electrical dysfunction, mechanical decrements and arrhythmogenesis in mice; but (2) that 
UFCAPs, due to its size, would have a greater effect on the heart than FCAPs; and (3) that 
O3 co-exposure would potentiate the response elicited by both particle sizes. 
  
Aim 2) Determine the role of TRPA1 in acute cardiovascular dysfunction during 
exposure to air pollution.  Wild-type C57BL/6 (WT) and TRPA1 knockout (KO) mice were 
exposed to prototypical airway irritants acrolein and ozone to determine the role of TRPA1 in 
air pollution-induced cardiovascular dysfunction.  The cardiovascular response during 
exposure was characterized using radiotelemetry to record continuous electrocardiogram 
(ECG) in conscious, unrestrained animals, using whole body exposure chambers.  EGC 
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interval analysis, heart rate variability (HRV) analysis, and identification and quantification 
of arrhythmia were the primary endpoints.  Potential pollutant-driven alterations in cardiac 
mechanical function were evaluated post-exposure using a Langendorff cardiac perfusion 
preparation. The majority of research on TRP channels done thus far has utilized in-vitro 
methods or isolated organ perfusion systems.  While these techniques provided a great deal 
of insight regarding channel activation and elucidation of the neural pathways potentially 
involved in the adverse cardiopulmonary response to airway nerve activation, physiological 
endpoints in the whole organism could only be inferred.  Furthermore, the few studies 
identified which used whole organism, including the TRPA1 knockout mouse, generally 
anesthetized the animal prior to exposure, potentially confounding a reflex response.  
Previous studies from this lab have demonstrated that pharmacological inhibition of TRPA1 
attenuated the development of diesel exhaust-induced arrhythmia. Thus, this study sought to 
further establish a role for TRPA1 in air pollution induced cardiac dysfunction and we 
hypothesized that adverse cardiac electrical and mechanical responses due to acrolein or 
ozone were mediated by TRPA1. 
 
Aim 3) Characterize baseline autonomic tone and the effects of pharmacological 
inhibition of sympathetic or parasympathetic neurotransmission in wild-type and 
TRPA1 knockout mice with exposure to airway irritants.   
 HRV is an indirect measure of autonomic influence on the heart which represents 
input from homeostatic control mechanisms that dynamically regulate cardiovascular and 
respiratory function.  My previous studies demonstrate that air pollution exposure modulates 
cardiac function and increases arrhythmia in mice through altered autonomic balance.  To 
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fully determine the degree of autonomic modulation which results from TRPA1-mediated 
sensory activation in the airways we need to better understand baseline cardiac autonomic 
properties in our model, as well as how these measures change with exposure. Hence, I 
explored how pharmacological blockade of each autonomic branch affects measures of HRV 
as well as the cardiac response to air pollution in mice.  Wild-type C57BL/6 (WT) and 
TRPA1 (KO) mice were treated with one of three pharmacological agents producing either 
sympathetic blockade, parasympathetic blockade, or blockade of both branches of the 
autonomic nervous system, before being exposed to filtered air or acrolein.  We hypothesized 
that pharmacological disruption of normal autonomic balance in the mouse would disrupt 
basic cardiovascular function as shown by heart rate and heart rate variability as well as blunt 
the cardiac response to acrolein. 
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CHAPTER II:  OZONE CO-EXPOSURE MODIFIES CARDIAC RESPONSES TO 
FINE AND ULTRAFINE AMBIENT PARTICULATE MATTER IN MICE: 
CONCORDANCE OF ELECTROGRAM AND MECHANICAL RESPONSES 
 Studies have shown a relationship between air pollution and increased risk of 
cardiovascular morbidity and mortality. Due to the complexity of ambient air pollution 
composition, recent studies have examined the effects of co-exposure, particularly particulate 
matter (PM) and gas, to determine whether pollutant interactions alter (e.g. synergistically, 
antagonistically) the health response. This study examines the independent effects of fine 
(FCAPs) and ultrafine (UFCAPs) concentrated ambient particles on cardiac function, and 
determine the impact of ozone (O3) co-exposure on the response. We hypothesized that 
UFCAPs would cause greater decrement in mechanical function and electrical dysfunction 
than FCAPs, and that O3 co-exposure would enhance the effects of both particle-types.  
Conscious/unrestrained radiotelemetered mice were exposed once whole-body to either 190 
μg/m3 FCAPs or 140 μg/m3 UFCAPs with/without 0.3 ppm O3; separate groups were 
exposed to either filtered air (FA) or O3 alone. Heart rate (HR) and electrocardiogram (ECG) 
were recorded continuously before, during and after exposure, and cardiac mechanical 
function was assessed using a Langendorff perfusion preparation 24 hrs post-exposure. 
FCAPs alone caused a significant decrease in baseline left ventricular developed pressure 
(LVDP) and contractility, whereas UFCAPs did not; neither FCAPs nor UFCAPs alone 
caused any ECG changes. O3 co-exposure with FCAPs caused a significant decrease in heart 
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rate variability when compared to FA but also blocked the decrement in cardiac function. On 
the other hand, O3 co-exposure with UFCAPs significantly increased QRS-interval, QTc and 
non-conducted P-wave arrhythmias, and decreased LVDP, rate of contractility and relaxation 
when compared to controls.  These data suggest that particle size and gaseous interactions 
may play a role in cardiac function decrements one day after exposure. Although FCAPs + 
O3 only altered autonomic balance, UFCAPs + O3 appeared to be more serious by increasing 
cardiac arrhythmias and causing mechanical decrements. As such, O3 appears to interact 
differently with FCAPs and UFCAPs, resulting in varied cardiac changes, which suggests 
that the cardiovascular effects of particle-gas co-exposures are not simply additive or even 
generalizable. Additionally, the mode of toxicity underlying this effect may be subtle given 
none of the exposures described here impaired post-ischemia recovery. 
Introduction 
 Risk assessments of air pollution health effects have become increasingly challenging 
given the complexity of present-day air pollution mixtures. Epidemiological studies indicate 
that fine (PM2.5) and ultrafine (PM0.1) particulate matter (PM) are the principal instigators of 
adverse clinical events, particularly those involving the cardiovascular system (Brook et al. 
2010). However, air pollution is a mixture of not only PM, but also gaseous irritants, vapors, 
and biological substances; thus when examining the effects of any given pollutant, the 
influence of other components must be considered. As such, studies need to determine whether 
the resultant physiological and biochemical effects of multipollutant exposures represent the 
simple additive effects of the pollutants, their synergism or antagonism. One particularly 
relevant interaction is that of PM and the ubiquitous gaseous co-pollutant O3. 
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 Although studies have examined the effects of sequential exposures, for example, 
ozone (O3) and then PM2.5 causes decreased HRV, systolic blood pressure and heart rate (HR) 
in rat (Wang et al. 2013), only a few studies have addressed the health effects of simultaneous 
exposures with distinct pollutants and the effects are still not fully clear. For instance, Brook 
et al. demonstrated acute arterial vasoconstriction in healthy subjects co-exposed to PM2.5 and 
O3 (Brook et al. 2002), whereas Urch et al. (Urch et al. 2005) found no significant changes in 
mean arterial pressure, systolic blood pressure or HR in a similar study population; although 
constriction was observed with PM2.5 alone. Animal studies also indicate that the effect of 
combining pollutants does not necessarily yield the expected synergistic response, especially 
in the case of susceptible models. Wagner et al. recently showed that depression of heart rate 
and blood pressure during PM2.5 and O3 co-exposure was not as great as either pollutant alone 
in rats fed a high-fructose diet (Wagner et al. 2013). The respiratory effects of O3 and PM co-
exposure are equally conflicting. For example, rats instilled with ozonized DEP had increased 
inflammatory cells and protein in the lungs (Madden et al. 2000), whereas mice co-exposed to 
O3 and DEP did not have increased cytotoxicity or inflammation (Farraj et al. 2010). Instead, 
in this latter study, co-exposed mice had increased bronchoconstriction, which is a measure of 
lung function. Similar investigations into the effects of simultaneous exposure on cardiac 
function have not been widely conducted. 
 Rodent electrocardiograms (ECG) can provide valuable insight into cardiovascular 
function in air pollution studies, particularly when pollutant concentrations are low and overt 
inflammation or toxicity are not observed. ECG is now routinely used in rodents for the 
detection of disturbances in myocardial impulse formation and conduction, as well as abnormal 
cardiac rhythm and altered autonomic regulation of the heart. As such, a wide range of cardiac 
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responses demonstrated by controlled human and animal PM exposure studies have provided 
biological plausibility to the health effects of air pollution (Brook et al. 2010; Dockery et al. 
1993; Kodavanti et al. 2011; Peters 2005).  Some of these are responses observed using ECG 
and have been shown to be similar in humans and animals (Hazari, Callaway, Winsett, Lamb, 
Haykal-Coates, et al. 2012; Mills et al. 2007). For instance, some human subjects exposed to 
PM have decreased heart rate variability (HRV), which is a predictor of increased risk (Tsuji 
et al. 1996; Tsuji et al. 1994; Gold et al. 2000; Gong et al. 2004), and enhanced 
arrhythmogenesis (Zareba et al. 2009). Experiments in animals not only show a similar PM-
induced decrease in HRV and increased incidence of arrhythmia (Brook et al. 2010), but also 
functional decrements in the heart such as diminished left ventricular developed pressure 
(LVDP) and decreased contractility (Chen & Hwang 2005; Gurgueira et al. 2002; Hwang et 
al. 2008). On the other hand, few studies, if any, have examined the effects of simultaneous 
PM and O3 exposure on both ECG and mechanical function (e.g. contractility) of the heart. 
 Thus, the purpose of this study was to determine the effects of concentrated ambient 
particles (CAPs), with and without O3 co-exposure, on cardiac electrical and mechanical 
function in mice. Previous data suggests that PM size determines the physiological impact with 
fine PM causing primarily pulmonary effects and ultrafine PM altering cardiac function (Tong 
et al. 2010; Amatullah et al. 2012). We hypothesized (1) that inhalation of either fine (FCAPs) 
or ultrafine CAPs (UFCAPs) would cause cardiac electrical dysfunction, mechanical 
decrements and arrhythmogenesis in mice; but (2) that UFCAPs, due to its size, would have a 
greater effect on the heart than FCAPs; and (3) that O3 co-exposure would potentiate the 
response elicited by both particle sizes, respectively. 
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Materials and Methods 
Animals - Ten to twelve-week old female C57BL/6 mice (body weight = 21.6 ± 0.1 g) were 
used in this study (Jackson Laboratory - Bar Harbor, ME). Mice were initially housed five 
per cage and maintained on a 12-hr light/dark cycle at approximately 22°C and 50% relative 
humidity in an AAALAC–approved facility. Food (Prolab RMH 3000; PMI Nutrition 
International, St. Louis, MO) and water were provided ad libitum. Each mouse implanted 
with a radiotelemeter was singly housed after surgery. All protocols were approved by the 
Institutional Animal Care and Use Committee of the U.S. Environmental Protection Agency 
and are in accordance with the National Institutes of Health Guides for the Care and Use of 
Laboratory Animals. The animals were treated humanely and with regard for alleviation of 
suffering. 
Experimental Groups - Mice were randomly assigned to one of six exposure groups: (1) 
fine concentrated ambient particles (FCAPs); (2) ultrafine CAPs (UFCAPs); (3) ozone (O3); 
(4) FCAPs and O3 co-exposure (FCAPs + O3); (5) UFCAPs and O3 co-exposure (UFCAPs + 
O3); and (6) filtered air (FA). Each group had n = 6. Separate groups (same as above) of mice 
were used for Langendorff cardiac perfusion experiments (n = 5-8). 
Surgical implantation of radiotelemeters - Animals were weighed and then anesthetized 
using inhaled isoflurane (Isothesia, Butler Animal Health Supply, Dublin OH). Anesthesia 
was induced by spontaneous breathing of 2.5% isoflurane in pure oxygen at a flow rate of 1 
L/min and then maintained by 1.5% isoflurane in pure oxygen at a flow rate of 0.5 L/min; all 
animals received the analgesic Buprenorphrine (0.03 mg/kg, i.p. manufacturer). Briefly, 
using aseptic technique, each animal was implanted subcutaneously with a radiotelemeter 
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(ETA-F10, Data Sciences International, St Paul, MN); the transmitter was placed under the 
skin to the right of the midline on the dorsal side. The two electrode leads were then tunneled 
subcutaneously across the lateral dorsal sides; the distal portions were fixed in positions that 
approximated those of the lead II of a standard electrocardiogram (ECG). Body heat was 
maintained both during and immediately after the surgery. Animals were given food and 
water post-surgery and were housed individually. All animals were allowed 7-10 days to 
recover from the surgery and reestablish circadian rhythms. 
Radiotelemetry data acquisition - Radiotelemetry methodology (Data Sciences 
International, Inc., St. Paul, MN) was used to track changes in cardiovascular function by 
monitoring heart rate (HR), and ECG waveforms immediately following telemeter 
implantation, through exposure until 24 hours post-exposure. This methodology provided 
continuous monitoring and collection of physiologic data from individual mice to a remote 
receiver. Sixty-second ECG segments were recorded every 5 minutes during the pre- and 
post-exposure periods and continuously during exposure (baseline and hours 1-4); HR was 
automatically obtained from the waveforms (Dataquest ART Software, version 3.01, Data 
Sciences International, St. Paul, MN, USA). 
Electrocardiogram analysis - ECGAuto software (EMKA Technologies USA, Falls Church 
VA) was used to visualize individual ECG waveforms, analyze and quantify ECG segment 
durations and areas, as well as identify cardiac arrhythmias as previously described (Hazari et 
al. 2014). Briefly, using ECGAuto, P-wave, QRS complex, and T-wave were identified for 
individual ECG waveforms and compiled into a library. Analysis of all experimental ECG 
waveforms was then based on established libraries. The following parameters were 
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determined for each ECG waveform: PR interval (Pstart-R), QRS complex duration (Qstart-S), 
ST segment interval (S-Tend) and QT interval (Qstart-Tend). QT interval was corrected for HR 
using the correction formula for mice QTc = QT/(RR/100)1/2(Mitchell et al. 1998). Figure 3A 
and B show a typical ECG trace as well as a typical non-conducted p-wave (NCPW) 
arrhythmia, which indicates an intermittent atrioventricular block, as observed in mice, 
respectively. 
HRV Analysis - Heart rate variability (HRV) was calculated as the mean of the differences 
between sequential RRs for the complete set of ECG waveforms using ECGAuto. For each 
1-min stream of ECG waveforms, mean time between successive QRS complex peaks (RR 
interval), mean HR, and mean HRV-analysis–generated time-domain measures were 
acquired. The time-domain measures included standard deviation of the time between 
normal-to-normal beats (SDNN), and root mean squared of successive differences (RMSSD). 
HRV analysis was also conducted in the frequency domain using a fast-Fourier transform. 
The spectral power obtained from this transformation represents the total harmonic 
variability for the frequency range being analyzed. In this study, the spectrum was divided 
into low-frequency (LF) and high-frequency (HF) regions. The ratio of these two frequency 
domains (LF/HF) provides an estimate of the relative balance between sympathetic (LF) and 
vagal (HF) activity. 
Concentrated ambient particle and ozone exposure - Concentrated ambient particles 
(CAPs) and ozone (O3) were generated in the U.S. EPA’s Concentrated Air Particles 
Laboratory, Research Triangle Park, NC. All exposures were carried out in the summer 
months of June and July and under sunny and warm climate conditions. Ambient air 
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containing PM from outside the facility entered the systems and passed through a size 
selective inlet removing PM > 2.5 μm so that remaining particles were in the size fractions of 
interest. The largest source of PM was from mobile sources (≈20%), wood combustion 
(≈21%), road dust (≈4%) and other minor sources such as brake wear and marine salt; the 
remaining PM was from secondary sulfates (≈50-55%). Incoming air was then split into two 
streams and particles were selectively concentrated into either the fine (0.1 to 2.5 μm) or 
ultrafine mode (<300 nm) and then delivered into two separate chambers. Real time 
measurements of number concentration and particle size distribution were performed using a 
scanning mobility particle sizer (SMPS) and an Aerodynamic Particle Sizer (APS). A 
generator was used to produce O3 (0.3 ppm), which was then delivered to a third chamber. 
Chamber plumbing was altered to allow different configurations of concentrated PM and/or 
O3 including: FCAPs alone, UFCAPs alone, FCAPs + O3, UFCAPs + O3, O3 alone, or 
filtered air (FA). Exposure to FCAPs/UFCAPs alone had to be done on separate days from 
FCAPs/UFCAPs co-exposures with O3 due to limitations in the exposure system (i.e. 
exposure to CAPs alone and CAPs + O3 could not be done on the same day); day-to-day 
variations in particle concentrations and composition were expected due to this. The study 
protocol included two days of animal-to-chamber acclimatization prior to exposure. A 
normal four-hour exposure (Exp1 (exposure hour 1), Exp2, Exp3, and Exp4) started with one 
hour of additional chamber acclimatization (Baseline). All mice were moved back to their 
home-cages after the exposure (Recovery). The Multiple Pathway Particle Dosimetry 
(MPPD; Version 3.0) model was used to estimate particle doses (Anjilvel & Asgharian 1995; 
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Cassee et al. 2002) for mice and humans; ventilatory parameters were estimated using typical 
values (Méndez et al. 2010). 
Cardiac Perfusion - The procedure for cardiac perfusion has been previously described 
(Tong et al. 2010). Briefly, 24 hours after exposure, mice were anesthetized with sodium 
pentobarbital (80 mg/kg, i.p.). Heparin (100 units) was injected intravenously before removal 
of heart. The hearts were rapidly removed and placed in ice-cold Krebs-Henseleit buffer, 
after which the aortas were cannulated. Retrograde perfusion via the aorta was performed 
under constant pressure (100 cmH2O) above the heart. The non-recirculating perfusate was a 
Krebs-Henseleit buffer containing (in mmol/L) 120 NaCl, 5.9 KCl, 1.2 MgSO4, 1.75 CaCl2, 
25 NaHCO3, and 11 glucose. The buffer was aerated with 95% O2—5% CO2 and maintained 
at pH 7.4 and a temperature of 37°C. For assessment of contractile function, a latex balloon 
on the tip of a polyethylene catheter was inserted through the left atrium into the left 
ventricle. The catheter was connected to a pressure transducer (Argon Medical Devices, 
Athens, TX) at the same height as the heart. The pressure of the left ventricular balloon was 
inflated to 0-5 cmH2O. A PowerLab system was used to collect and process the heart rate, 
left ventricular developed pressure (LVDP = LV peak minus end-diastolic pressure 
(LVEDP)), and contractility (dP/dt) data (AD Instruments, Milford, MA). All hearts were 
perfused for 25 min; we then initiated 20 min of global no-flow ischemia by stopping the 
flow of oxygenated perfusion buffer, followed by 1 h of reperfusion. Onset of ischemic 
contracture was measured as the time from the start of ischemia until initial contracture (at 
least 5 cmH2O increase in left ventricular pressure). Recovery of LVDP, expressed as a 
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percentage of the initial pre-ischemic LVDP, was measured at 20, 40 and 60 min of 
reperfusion after 20 min of ischemia. 
Tissue collection and analysis - See Additional file 1 for full details, procedures were 
performed as previously described (Farraj et al. 2010). Briefly, 24 hrs after exposure, mice 
were euthanized and blood and lung lavage fluid (BAL) were collected, processed and 
analyzed. Multiple biochemical markers (e.g. lactate dehydrogenase, protein, etc) were 
assessed in the BAL, and serum or plasma supernatants were analyzed for creatine kinase, C-
reactive protein (CRP), and other markers to assess cardiopulmonary inflammation, injury 
and oxidative stress. 
Statistics - All data are expressed as means ± SEM. Statistical analyses of the data were 
performed with GraphPad Prism 5 (GraphPad software, San Diego CA). For HR, ECG 
intervals and HRV, two-way analysis of variance (ANOVA) for repeated-measures and 
Bonferroni post hoc tests were used to determine statistical differences. A one-way ANOVA 
was used to analyze arrhythmia counts. For Langendorff cardiac perfusion data, comparisons 
between groups were performed by one-way ANOVA followed by Bonferroni post hoc test 
for multiple comparisons. Comparisons were made across all groups taking into account the 
multiple endpoints, exposure groups and time points as well as any interactions. An oblique 
principal component cluster analysis and multivariate analysis of variance (MANOVA – 
GLM procedure and least squares means post hoc test) were performed using SAS version 
9.3 software, (SAS Institute Inc, Cary, NC) to determine whether the elements found in the 
CAPs on their own or in combination with one another had an effect on the cardiac 
responses. The objective of this approach was to reduce the large number of variables (i.e. 
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elements) to a smaller set that still retain the information in the original data set and then 
examine for effects. Five clusters were revealed and elements belonging to the same cluster 
had strong correlations. A p-value < 0.05 was considered statistically significant. 
Results 
Chamber and exposure characteristics - Table 1 shows the concentration and particle size 
of CAPs and O3, and chamber characteristics for each exposure group. Table 2 indicates the 
elemental composition of the particulate matter from each of the exposure groups. Other than 
iron (Fe), FCAPs and UFCAPs particulate matter were of similar composition with the 
majority of the elemental fraction composed of SO4. 
Estimated particle doses - The following particle doses were calculated for the mice in each 
of the PM-exposed group: (1) UFCAPs - 0.418 μg (2) FCAPs - 0.426 μg (3) UFCAPs + O3 - 
0.264 μg and (4) FCAPs + O3 - 0.446 μg. Using the same model and exposure characteristics 
the estimated human doses were determined to be: (1) UFCAPs - 103.4 μg (2) FCAPs - 81.3 
μg (3) UFCAPs + O3 - 65.8 μg and (4) FCAPs + O3 - 85.0 μg. 
Heart Rate - Although all animals experienced an increase in HR while in the exposure 
chamber before the start of the exposure (Baseline) and a progressive decrease during the 4-
hour exposure (Exp1, Exp2, Exp3 and Exp4), there were no significant differences in HR 
among any of the exposure groups during any time period (Figure 1). 
Heart rate variability (HRV) - Exposure to FCAPs + O3 caused a significant decrease in 
the SDNN (4.8 ± 0.4 ms) compared with FA controls (7.7 ± 0.5 ms) (Figure 1). No other 
significant differences in time-domain HRV measurements were found among any of the 
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exposure groups pre-, during or post-exposure. There were also no significant differences in 
the LF/HF between any exposure groups. 
Electrocardiogram - Figure 2 shows the electrocardiogram data before, during and after 
exposure. There were no significant differences in ECG between any of the groups during 
pre-exposure or recovery. All animals experienced a decrease in PR interval, QRS, ST 
interval, and QTc during the baseline, which was likely related to the increase in HR. 
Thereafter, PR interval and ST interval increased in all animals during the exposure; though 
there were no significant differences. In contrast, QRS and QTc were significantly increased 
in mice exposed to UFCAPs + O3 when compared to FA. Exposure to O3 alone demonstrated 
a trend towards decreased QTc when compared with FA. 
Cardiac arrhythmia - There was a significant increase in the number of non-conducted P-
wave arrhythmias during the 4-hour exposure period to UFCAPs + O3 when compared with 
FA (Figure 3C). No other significant differences in arrhythmias were observed among any of 
the exposure groups. Although other types of arrhythmias were noted, they were few in 
number and not statistically different between any of the groups. 
Cardiac effects before ischemia - Post-exposure (baseline) hemodynamics and the onset 
time to ischemic contracture for each of the exposure groups are listed in Table 3. As shown 
in Figure 4, there was a significant decrease in LVDP in the FCAPs (31.9 ± 6.7 cmH2O), O3 
(54.7 ± 12.6 cmH2O) and UFCAPs + O3 (45.0 ± 9.2 cmH2O) groups compared to FA (96.7 ± 
9.6 cmH2O) 24 hours after exposure and before ischemia. Left ventricular contractility was 
also significantly depressed in the UFCAPs, FCAPs, O3 and UFCAPs + O3 groups compared 
to the FA control group. The maximum dP/dt was significantly lower in FCAPs (1397 ± 296 
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cmH2O/sec), O3 (2483 ± 480 cmH2O/sec) and UFCAPs + O3 (1975 ± 306 cmH2O/sec) when 
compared to FA (3880 ± 208 cmH2O/sec) and the minimum dP/dt before ischemia was also 
significantly lower in the UFCAPs (-1452 ± 395 cmH2O/sec), FCAPs (-982 ± 259 
cmH2O/sec), O3 (-1520 ± 318 cmH2O/sec) and UFCAPs + O3 (-1323 ± 286 cmH2O/sec) 
groups when compared to FA (-2744 ± 317 cmH2O/sec) (Figure 5; Table 3). There was no 
difference in HR, coronary flow rate or ischemic contracture between any exposure groups 
before ischemia (Table 3). 
Multivariate analysis of variance demonstrated that differences in LVDP, maximum dP/dt and 
minimum dP/dt between the FCAPs alone and FCAPs + O3 groups could be accounted for by 
the decrease in aluminum (Al), barium (Ba), copper (Cu), iron (Fe) or silicon dioxide (SiO2) 
compositions (Table 2); these elements clustered together however the analysis could not 
determine which element specifically was responsible. There were no apparent differences in 
elemental composition between UFCAPs alone and UFCAP + O3, except nickel (Ni), which 
were linked to any cardiac response changes, nor were there any other significant linkages with 
any other cardiac endpoints. 
Cardiac Effects Post-Ischemia - After ischemia there were minimal differences among the 
groups. There was a significant decrease in HR 20 min after reperfusion in the O3 group 
(213.8 ± 14.2 bpm) compared to FA (285.3 ± 17.5 bpm) (Figure 6). There were no 
differences in the post-ischemia coronary flow rates of any of the groups. Although all 
groups experienced a significant decrease in LVDP recovery when compared to pre-
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ischemia, there was no significant difference in post-ischemia recovery of LVDP (Figure 7), 
dP/dtmax, and dP/dtmin between any exposure groups. 
Biochemical markers and inflammatory cells in BAL and blood - Exposure to O3 alone or 
UFCAPs + O3 caused a significant decrease in glutathione S-transferase (GTR) when 
compared to controls. There were no other significant differences in any other BAL cells or 
markers, or any of the serum or plasma markers (Table 4). 
Discussion 
 This study demonstrates that a single inhalation exposure to either FCAPs or UFCAPs 
differentially affects cardiac mechanical and electrical responses in mice, and that the effect of 
O3 co-exposure on the response varies for each particle size. FCAPs alone caused decreased 
ventricular contractility but contrary to our original hypothesis UFCAPs alone had no effect. 
However, introduction of O3 as a co-pollutant with UFCAPs caused a significant decrease in 
cardiac contractility 24 hours after exposure and blunted the effects of FCAPs. In contrast, 
although exposure to either FCAPs or UFCAPs alone did not cause any significant 
electrocardiogram effects, co-exposure to each with O3 caused electrical and HRV changes 
that might indicate increased cardiac risk. Overall, our results demonstrate that UFCAPs + O3 
produces the most significant effects across both mechanical and electrical cardiac function 
(Table 5.). Thus, these data suggest there is a differential effect of particle size, which holds 
true in the presence or absence of O3, confirming the health effects resulting from a PM-gas 
co-exposure are not simply the sum of both pollutants. Instead, it appears each interaction 
(FCAPs + O3 vs. UFCAPs + O3) is complex and needs to be examined separately, particularly 
when exposure concentrations are low and the responses are subtle. 
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 Our previous findings (Tong et al. 2010) suggested that UFCAPs would cause greater 
cardiac effects than FCAPs. Ultrafine black carbon particles have been shown to translocate 
into the blood circulation and have the potential to cause direct effects on the cardiovascular 
system (Takenaka et al. 2001; Furuyama et al. 2009). UF particles cause heterogeneity of 
repolarization and decreased HRV in humans (Samet et al. 2009), whereas mechanical 
assessments in animals reveal decreased LVDP, contractility and coronary flow (Hwang et al. 
2008; Tong et al. 2010; Bagate et al. 2006). In this study, animals were exposed via whole-
body inhalation as opposed to instillation (Tong et al. 2010; Bagate et al. 2006), direct 
perfusion (Hwang et al. 2008), or nasal inhalation (Amatullah et al. 2012), which could have 
resulted in a comparatively lower effective dose and milder response (Costa et al. 2006; Osier 
& Oberdörster 1997). However, among our animals, calculations of estimated total dose 
indicated that there was no difference between UFCAPs and FCAPs suggesting that in the 
absence of O3 more than just particle burden was responsible for the cardiac decrements. 
Instead, the site of deposition (i.e. pulmonary vs. extra-thoracic) may have played a more 
important role. FCAPs, which we estimated had a higher extra-thoracic deposition when 
compared to UFCAPs (0.232 μg vs. 0.142 μg, respectively), may have caused its effects 
through the activation of upper airway sensory mechanisms. Previous studies have shown that 
PM2.5 can cause irritation and subsequent activation of autonomic reflex arcs, particularly due 
to the presence of acidic components; UF particles did not produce the same response 
(Nadziejko et al. 2002). Thus, the higher relative exposure concentrations and differential 
deposition of FCAPs may have resulted in variable epithelial injury, inflammation, clearance 
and thus toxicological presentation (Johnson 2004). 
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 On the other hand, it is not entirely surprising that on their own FCAPs and UFCAPs 
did not cause any significant changes in ECG given our previous negative results with a more 
toxic pollutant (Farraj et al. 2009). Similarly, Campen et al. (Campen et al. 2006) found that 
Apolipoprotein E (ApoE) -/- mice on a high fat diet, which are assumed to be susceptible to 
the cardiotoxic effects of inhaled pollutants, did not have any ECG changes when exposed to 
high concentrations of road dust PM or the vapor phase of gasoline engine exhaust. As far as 
arrhythmias are concerned, spatial dispersion of cardiac repolarization, which contributes to 
arrhythmogenesis, is increased in people after co-exposure to CAPs and O3 with each pollutant 
causing minimal effects on their own (Sivagangabalan et al. 2011). Even in the presence of O3, 
it is clear from not only our results, but the previously mentioned human data and other humans 
studies (Fakhri et al. 2009), that relatively low CAPs exposures will likely only cause mild 
electrical and HRV changes in healthy populations. Thus, a significant ECG effect due to acute 
exposure may not necessarily be direct evidence of serious cardiovascular morbidity or 
premature mortality; rather, it may reflect a transient instability that can worsen if exposure 
continues over a longer period. 
 Co-exposure to UFCAPs and O3 produced electrophysiological changes indicative of 
increased heterogeneity of repolarization, as well as an increased incidence of non-conducted 
p-wave arrhythmias, which suggest atrioventricular block. In humans, this form of arrhythmia 
is usually seen with a wide QRS complex (Pelter & Adams 2003), which was also observed in 
our mice exposed to UFCAPs + O3; this sometimes indicates that conduction is impaired in 
the ventricles, particularly when observed with a block. These results corroborate findings 
from human studies of PM exposure (Baja et al. 2010; Tong et al. 2012) as well as human 
studies of PM and O3 co-exposure (Sivagangabalan et al. 2011). Similarly, a long QTc due to 
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prolonged repolarization suggests increased risk of early after-depolarization, which can 
trigger arrhythmias and potentially myocardial infarction when propagated. Indeed it is not 
unusual that electrical and mechanical dysfunction were both observed in mice exposed to 
UFCAPs + O3 given increased arrhythmogenesis has been shown to be associated with changes 
in myocardial stretch(Milan & MacRae 2005). 
 Consequently, clarifying the role of each pollutant in the health response is challenging. 
It has been suggested that PM may be the main driver of the cardiovascular response in some 
instances with O3 acting as a modifier. Brook et al. previously showed that PM and O3 together 
cause acute arterial vasoconstriction in healthy humans subjects, but so does PM alone (Brook 
et al. 2002; Brook et al. 2009). However, we observed depression of mechanical function with 
O3 alone; although much of the current research is focused on PM as a cardiotoxicant, several 
studies have also noted the adverse cardiovascular effects of O3 inhalation; which include 
decreased HR, alteration of cardiac repolarization, and increased inflammation (Kodavanti et 
al. 2011; Whitsel et al. 2009; Farraj et al. 2012; McIntosh-Kastrinsky et al.). As such, the type 
of cardiac responses following air pollution may be dependent on the type of pollutant, or 
combination of pollutants, with some degree of overlapping effects. Tankersley et al. 
(Tankersley et al. 2010) showed that both carbon black particles and O3 caused reduced cardiac 
output in mice but due to two different mechanisms. Thus, we speculate that although both 
particles and gases produce similar cardiac decrements, the mechanisms mediating the 
response may not be the same (e.g. translocation vs. airway sensory irritation). Combinations 
of pollutants only complicates the assessment due the involvement of various separate or 
overlapping mechanisms. Regardless, the responses appear to be independent of total particle 
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dose or even pulmonary deposition given UFCAPs was estimated to be less than FCAPs 
(pulmonary dose - 0.104 μg vs. 0.135 μg, respectively). 
 The role of the autonomic nervous system cannot be entirely discounted either; as 
demonstrated through HRV, the responses observed here and in other studies with respect to 
PM exposure appear to be dependent on the size of the particles. The interpretation and 
importance of HRV in air pollution studies is still not entirely agreed upon, particularly when 
examining populations with underlying cardiovascular disease. Mills et al. (Mills et al. 2011) 
and Perez et al. (Peretz et al. 2008) did not observe any HRV changes in humans exposed to 
diesel exhaust, however this lack of effect does not necessarily imply that there are no 
autonomic changes, instead a trigger (e.g. stress, exercise, etc) may be necessary to reveal any 
HRV differences. On the other hand, some studies show that particles, especially fine, cause 
HRV effects in humans. Several studies have demonstrated that exposure to FCAPs causes 
decreased HRV in young healthy or elderly adults (Devlin et al. 2003; Pope et al. 2004; Gold 
et al. 2000) with O3 co-exposure only potentiating the response (Gold et al. 2000). In healthy 
young adults, there was no dose-response relationship between FCAPs mass and HRV, 
however when combined with O3, increases in CAPs mass decreased HRV in a dose-dependent 
manner (Fakhri et al. 2009). On the other hand, UFCAPs either have no effect (Schneider et 
al. 2010) or increase HRV (Zareba et al. 2009; Samet et al. 2009) or the results are less 
conclusive across all studies. Long-term exposure to UFCAPs, or a higher concentration, may 
have caused a significant change in HRV given these particles have the ability to penetrate 
deep into the lung, cause inflammation and activate autonomic reflex pathways (Carll et al. 
2010). 
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 Some of these pathways may lead to subsequent ischemic damage, which has been 
shown to be increased by PM. Cozzi et al. showed that in mice intra-tracheally instilled with 
ultrafine PM, infarct size and oxidative stress in the myocardium were significantly increased 
(Cozzi et al. 2006). This corroborates our previous PM instillation studies which also 
demonstrated an increase in post-ischemia infarct size and decreased recovery of LVDP (Tong 
et al. 2010). It appears that the method of exposure significantly impacts the post-ischemia 
response because even though exposure to FCAPs or UFCAPs + O3 caused significant pre-
ischemia functional decrements, there was no change in coronary flow post-ischemia and there 
appeared to be an improvement of LVDP recovery (Figure 7). These findings are similar to 
what we observed with inhalation of multipollutant mixtures (McIntosh-Kastrinsky et al. 2013) 
and may represent activation of some compensatory mechanism post-exposure that actually 
protects the heart during ischemic injury. Lastly, although infarct size was not measured in our 
animals, we theorize that there was probably minimum to no increase particularly given we 
previously observed a decrease in infarct size with multipollutant mixture inhalation 
(McIntosh-Kastrinsky et al. 2013). Thus, acute inhalation of fine or ultrafine PM alone or in 
combination with O3 may not be potent enough to cause serious ischemia-related damage and 
that a higher concentration is necessary to overcome this apparent response threshold. 
 Other than the mode of exposure, the chemical and physical characteristics of the PM 
might also account for some of the differences in response observed in this study. Indeed it is 
a limitation that exposure to CAPs alone could not be done on the same days as CAPs + O3; 
this accounts for the variation in not only particle numbers but composition as well. However, 
it is our assertion that the responses to these “real-world” particle concentrations are important, 
especially given the daily fluctuation of particulate air pollution and the ubiquitousness of O3. 
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It is also important to note that although we compare these results to our previous study (Tong 
et al. 2010), the composition of the current FCAPs and UFCAPs is different. Our CAPs, 
particularly the UFCAPs, had a higher organic (OC) and total carbon (TC) content; thus 
possibly explaining the differences in response. 
 As such, there was a 1/3rd of Cu and ½ the Fe in the FCAPs + O3 exposure when 
compared to FCAPs alone which may have contributed to the lack of effect in the former. 
There was also an increase in Ni and Cu, which have been shown to be two of the most toxic 
metals found in PM (Riley et al. 2003), in the UFCAPs + O3 exposure when compared to 
UFCAPs alone. In contrast, even though it appears that mass was not a factor in the observed 
decrements because there was less PM in the UFCAPs + O3 exposure than UFCAPs alone and 
the opposite for the FCAPs and O3 co-exposures, there was a significantly higher sulfate and 
OC/TC content in the UFCAPs, especially the UFCAPs + O3, when compared to FCAPs, 
which may explain the larger cardiac effect (Chuang et al. 2007). On the other hand, responses 
to FCAPs and UFCAPs combined with O3 might also be partially explained by the chemical 
changes occurring in PM upon ozonization. Ozone is highly reactive and therefore it has the 
potential to react with certain components of PM such as the aromatic compounds (Madden et 
al. 2000). It has been documented that ozonization of aromatic substances can result in the 
formation of carbonyls, carboxylic acids, quinones, and epoxides, which can be more toxic 
than the parent compound (Kozumbo & Agarwal 1990; Pitts et al. 1980), but also less potent 
due to “over-ozonization” (Madden et al. 1993). It is yet unclear which mechanism is at play 
here. 
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 Additionally, O3 may cause epithelial injury and oxidative stress, which facilitate the 
PM effects (Elder et al. 2000). Adamson et al. (Adamson et al. 1999) showed that O3 and urban 
particulate co-exposure resulted in greater epithelial injury and interstitial inflammation than 
for either component alone; not to mention UFP did not have a large biological effect without 
O3. As such, co-exposures may produce differential responses due to toxicological interactions 
within the host. Thomson et al. (Thomson et al. 2005) showed that on their own, PM and O3 
increased expression of the potent vasoconstrictor endothelin-1 (ET-1) in the lungs and its 
circulating levels in the plasma, however, together they only caused an upregulation (i.e. 
without plasma “spill-over”). Although there were no significant changes in inflammatory cells 
or markers in the blood or lavage, we found that O3 alone and UFCAPs + O3, but not FCAPs 
or UFCAPs alone, caused significantly decreased serum glutathione S-transferase (GTR) 
levels, which is indicative of increased oxidative stress; direct measurement of oxidative stress 
in the myocardium may have revealed a greater involvement as was shown by Cozzi et al. 
(2006) (Cozzi et al. 2006). Wang et al. previously showed that PM2.5 and O3 increased several 
markers of inflammation and oxidative stress in rats however their exposure concentrations 
were significantly higher than those used here (Watkinson et al. 2001). Regardless, synergistic 
interactions between inhalable PM and O3 can increase the generation of reactive oxygen 
species due to the porous surface of particles which provides ample surface area for reactivity, 
but that the potency still depends on particle concentration, size and other factors (Valavanidis 
et al. 2009; Park et al. 2006). 
 The results of this study demonstrate that fine and ultrafine CAPs differentially alter 
cardiac responses, which include both mechanical and electrical effects. More importantly, 
these data clearly show that the effects of co-exposure may not be simply additive or 
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synergistic, nor even generalizable. Although only fine CAPs had significant effects on its 
own, O3 co-exposure with FCAPs caused decreased HRV whereas with UFCAPs caused 
electrical changes and arrhythmia. Interestingly, O3 co-exposure only caused mechanical 
decrements with UFCAPs and to our surprise blunted the effects of FCAPs. This indicates that 
the size, and potentially the chemical composition, of the particle is an important determinant 
of the type of cardiac response, particularly when gaseous co-pollutants are present. Although 
the responses were subtle, the important message may be that latent underlying changes are 
occurring post-exposure and that the deleterious effects of even a single exposure to air 
pollution needs to be considered. Some of these might not manifest as overt symptoms, 
however the latent effect might not be any less serious, instead increasing the susceptibility to 
subsequent triggered adverse responses (i.e. due to loss of compensatory capacity), particularly 
in people with existing cardiovascular disease. 
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Tables and Figures 
Table 1. Chamber and exposure characteristics 
 GROUPS 
 FA UFCAPs UFCAPs + O3 FCAPs FCAPs + O3 O3 
Temperature 
(°C) 
22.3 ± 0.1 23.0 ± 0.1 22.6 ± 0.1 22.0 ± 0.1 22.2 ± 0.1 22.5 ± 0.2 
Rel. humidity 
(%) 
50.2 ± 0.7 70.5 ± 4.6 56.0 ± 3.6 59.8 ± 3.4 59.0 ± 5.8 52.4 ± 2.2 
O3 (ppb) 4.0 ± 0.0 25.7 ± 4.7 298.3 ± 0.7 33.1 ± 2.0 300.0 ± 0.4 299.0 ± 1.1 
PM Mass 
(ug/m3) 
4.9 ± 2.2 138.8 ± 33.1 85.7 ± 6.5 190.9 ± 32.8 211.5 ± 37.3 3.4 ± 1.3 
PM Total # 
(particles/cc) 
24.2 ± 1.4 2.1E5 ± 5.6E3 1.6E5 ± 2.0E3 1.0E4 ± 5.2E1 1.1E4 ± 1.6E2 20.2 ± 4.2 
Particle size 
(um) 
- 0.076 0.072 0.246 0.235 - 
Geo. Std. Dev. - 1.67 1.66 1.96 1.67 - 
 PM CARBON 
TC (μg/m3) 3.4 ± 0.2 67.6 ± 6.5 
(48.7%) 
46.4 ± 3.4 
(54.1%) 
53.8 ± 4.4 
(28.2%) 
47.8 ± 7.3 
(22.6%) 
4.3 ± 0.4 
OC (μg/m3) 3.7 ± 0.2 64.5 ± 5.9 
(46.5%) 
44.6 ± 3.1 
(52.0%) 
50.3 ± 4.0 
(26.3%) 
45.7 ± 6.6 
(21.6%) 
4.6 ± 0.4 
EC (μg/m3) ** 3.1 ± 
0.6(2.2%) 
1.8 ± 0.3     
(2.1%) 
3.4 ± 0.5 
(1.8%) 
2.2 ± 0.7 
(1.0%) 
** 
Reported values are mean ± SEM for each group over all exposure days 
** = below detection limit 
Carbon percentages are by mass 
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Table 2. Elemental Composition of Particulate Matter in Exposure Groups 
Element(μg/m3) GROUPS 
FA UFCAPs UFCAPs + O3 FCAPs FCAPs + O3 O3 
Al --- BDL BDL 1.8364 0.8428⋄ --- 
As --- 0.0020 0.0040 0.0044 0.0077 --- 
Ba --- 0.0070 0.0047 0.0865 0.0480⋄ --- 
Ca --- BDL BDL 1.1741 0.6475 --- 
Cd --- 0.0005 0.0005 0.0015 0.0010 --- 
Co --- 0.0002 0.0002 0.0008 0.0006 --- 
Cr --- 0.0088 0.0198 0.0129 0.0134 --- 
Cu --- 0.0119 0.0727Δ 0.1550 0.0537⋄ --- 
Fe --- 0.0723 0.0848 2.1031 1.0555⋄ --- 
K --- 0.7448 0.4325 2.6025 1.3867 --- 
Li --- BDL BDL 0.0017 0.0013 --- 
Mg --- 0.0282 0.0254 0.5585 0.6145 --- 
Mn --- 0.0048 0.0058 0.0604 0.0348 --- 
Mo --- 0.0014 0.0032 0.0033 0.0036 --- 
Na --- 0.1491 0.2550 0.8990 3.7144 --- 
Ni --- 0.0053 0.0348Δ 0.0079 0.0084 --- 
P --- BDL BDL 0.1278 0.1565 --- 
Pb --- 0.0128 0.0124 0.0373 0.0271 --- 
SO4 --- 56.4662 39.8730 39.4038 49.3026 --- 
Sb --- 0.0035 0.0040 0.0146 0.0108 --- 
Se --- BDL BDL 0.0246 0.0248 --- 
SiO2 --- BDL BDL 4.9640 2.8436⋄ --- 
Sn --- 0.0182 0.0239 0.0151 0.0121 --- 
Sr --- 0.0016 0.0006 0.0179 0.0101 --- 
Ti --- BDL BDL 0.0691 0.0429 --- 
V --- 0.0023 0.0052 0.0092 0.0122 --- 
Zn --- 0.1527 0.0989 0.2171 0.2057 --- 
BDL - Below Detection Level 
--- Very low PM concentrations, insufficient sample mass for elemental analysis 
Δ Significantly different from UFCAPs 
⋄ Significantly different from FCAPs 
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Table 3. Baseline hemodynamic properties and the onset time to ischemic contracture 
Group (n = 6-8) LVDP 
(cmH2O) 
HR (bpm) Flow rate 
(mL/min) 
dP/dtmax 
(cmH2O/sec) 
dP/dtmin 
(cmH2O/sec) 
Time to 
contractu
re (min) 
FA 96.7 ± 9.6 306.6 ± 17.5 1.7 ± 0.3 3880 ± 208 -2744 ± 317 14.3 ± 1.9 
UFCAPs 59.7 ± 15.4 270.3 ± 19.6 1.7 ± 0.5 2564 ± 825 -1452 ± 395 14.6 ± 1.8 
UFCAPs + O3 45.0 ± 9.3* 295.1 ± 18.5 2.0 ± 0.5 1975 ± 306* -1323 ± 286* 15.1 ± 1.6 
FCAPs 31.9 ± 6.7* 301.3 ± 27.6 5.7 ± 2.9 1397 ± 296* -981 ± 259* 11.1 ± 0.5 
FCAPs  + O3 88.0 ± 18.4 277.6 ± 15.7 1.7 ± 0.2 3034 ± 528 -2219 ± 394 12.9 ± 1.3 
O3 54.7 ± 12.6 246.3 ± 36.4 2.5 ± 0.6 2483 ± 480 -1520 ± 318 15.3 ± 1.6 
Values are means ± SEM. Flow rate = coronary flow rate; dP/dtmax = maximum 1st derivative 
of the change in left ventricular pressure/time; dP/dtmin = minimum 1st derivative of the change 
in left ventricular pressure/time; time to contracture = onset time to ischemic contracture. 
*Significantly different from FA; p < 0.05; n = 5-8. 
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Table 4. Biochemical markers in the bronchoalveolar lavage and serum 
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LDH – Lactate dehydrogenase 
MIA – Microalbumin 
NAG - N-acetyl-b-d-glucosaminidase 
ACE – angiotensin converting enzyme 
CK – Creatine Kinase 
CRP – C-reactive protein 
HBDH - α-hydroxybutyrate dehydrogenase 
GTR – glutathione-S-transferase 
SOD – Superoxide dismutase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
Table 5. Summary of effects 
G
ro
u
p
 
L
V
D
P
 
d
P
/d
t m
a
x
 
d
P
/d
t m
in
 
L
V
D
P
 r
ec
o
v
er
y
 
(p
o
st
-i
sc
h
em
ia
) 
C
o
ro
n
a
ry
 f
lo
w
 r
a
te
 
(p
o
st
-i
sc
h
em
ia
) 
H
ea
rt
 r
a
te
 
S
D
N
N
 
R
M
S
S
D
 
L
F
/H
F
 
Q
T
c 
N
C
P
W
 
F
A
 
--
 
--
 
--
 
--
 
--
 
--
 
--
 
--
 
--
 
--
 
--
 
U
F
C
A
P
s 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
U
F
C
A
P
s 
+
 O
3
 
↓
 
↓
 
↓
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
↑
 
↑
 
F
C
A
P
s 
↓
 
↓
 
↓
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
F
C
A
P
s 
+
 
O
3
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
↓
 
N
E
 
N
E
 
N
E
 
N
E
 
O
3
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
N
E
 
NE = No Effect 
↓ = significant decrease 
↑ = significant increase 
NOTE: the above responses are compared to Air 
 
56 
 
Figure 1. The effect of CAPs with and without O3 on heart rate and heart rate variability. 
Animals were placed in the chambers and allowed to acclimate for 1 hr before exposure 
(Baseline), then exposed for 4 hrs (shaded). Compared to pre-exposure, all animals 
experienced an increase in HR during baseline, then a progressive decrease from baseline 
during exposure. UFCAPs alone (UF) or with ozone (UF/O3) did not cause changes in HR or 
HRV at any time point (Column A.). Similarly, there was no effect of FCAPs alone (F) on 
any parameter; only exposure to FCAPs + O3 (F/O3) significantly decreased SDNN when 
compared to FA (Column B.). Exposure to ozone alone did not cause any significant effects 
(Column C.). Bracket indicates that each hour of the exposure period is significantly 
different. Values are mean ± SEM; *p < 0.05, significantly different from FA (n = 6). 
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Figure 2. Electrocardiogram effects before, during and after exposure to CAPs alone or 
with O3. Animals were placed in chambers acclimated for 1 hr before exposure (Baseline), 
then exposed for 4 hrs (shaded). All animals experienced a decrease in PR interval, QRS 
complex duration, ST interval and QTc from pre-exposure to baseline. Although both PR and 
ST intervals increased in all groups during exposure, there were no differences in either of 
these parameters among any of the groups. QRS also showed an increasing trend during 
exposure in all groups; however only mice exposed to UFCAPs + O3 had a significant 
increase in QRS and QTc when compared to FA (Column A.). There were no significant 
effects of FCAPs, with or without O3, or O3 alone at any time points (Column B. and C., 
respectively). Bracket indicates that each hour of the exposure period is significantly 
different. Values are mean ± SEM. p < 0.05; *significantly different from FA, ∆ significantly 
different from UFCAPs alone, □ significantly different from O3 alone (n = 6). 
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Figure 3. Typical mouse electrocardiogram and arrhythmia count during exposure. A. 
Typical mouse ECG during normal sinus rhythm and B. a non-conducted p-wave (NCPW) - 
represents a sudden loss of conduction from the atria to the ventricles. C. Non-conducted p-
waves were significantly increased only in mice exposed to UFCAPs + O3. Values are mean 
± SEM. p < 0.05; *significantly different from FA, ∆ significantly different from UFCAPs 
alone, □ significantly different from O3 alone (n = 6). 
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Figure 4. Effect of CAPs exposure on left ventricular developed pressure (LVDP). 
Exposure to FCAPs alone (F) significantly decreased LVDP at baseline (24 hrs after 
exposure - prior to ischemia) when compared to FA, however there was no effect with O3 co-
exposure. In contrast, UFCAPs alone had no effect on LVDP but with O3 co-exposure caused 
a significant decrease when compared to FA. Values are means ± SEM (n = 5-8/group). 
*Significantly different from FA; p < 0.05. 
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Figure 5. Effect of CAPs exposure with and without O3 on rate of left ventricle contractility 
and relaxation. Assessment of contractility (dP/dtmax - upper panel) and lusitropy (dP/dtmin - 
lower panel) were carried out at baseline 24 hrs after exposure - prior to ischemia. Exposure 
to FCAPs alone significantly decreased dP/dtmax and dP/dtmin at baseline when compared to 
FA, however there was no effect with O3 co-exposure (FCAPs/O3). In contrast, UFCAPs 
alone had no effect; but, O3 co-exposure with UFCAPs (UFCAPs/O3) caused both dP/dtmax 
and dP/dtmin to significantly decrease when compared to FA. Values are means ± SEM (n = 
5-8 in each group). *Significantly different from FA; p < 0.05. 
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Figure 6. Heart rate twenty minutes after ischemia-reperfusion. After 20mins of 
reperfusion, heart rate (HR) was significantly lower in animals exposed to O3 when 
compared to FA. There were no other significant differences in post-ischemia HR between 
any groups or at any other time point. Values are means ± SEM (n = 5-8 in each group). 
*Significantly different from FA; p < 0.05. 
 
 
Figure 7. Post-ischemia recovery of LVDP. Following ischemia, all animals experienced a 
significant decrease in recovery LVDP (expressed as a percentage of pre-ischemia) when 
compared to pre-ischemia. There were no significant differences among any groups in the 
recovery LVDP at 20 (R20), 40 (R40) or 60 (R60) minutes post-ischemia; however there was 
a trend towards increased%LVDP in the FCAPs, O3 and UFCAPs + O3 groups at R20, R40 
and R60 when compared to FA; consequently, these groups were the same ones 
demonstrating pre-ischemia changes. Values are means ± SEM (n = 5-8 in each group). 
*Significantly different from FA; p < 0.05.
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CHAPTER III:  TRPA1 MEDIATES CHANGES IN HEART RATE VARIABILITY 
AND CARDIAC MECHANICAL FUNCTION IN MICE EXPOSED TO ACROLEIN 
 Short-term exposure to ambient air pollution has been linked with adverse 
cardiovascular effects.  While most studies from the last ten years have focused on 
particulate matter-induced responses, gaseous components of air pollution have also been 
shown to cause short-term cardiovascular effects. The mechanisms underlying such effects 
have still not been adequately described yet it is clear that irritant neural activation and 
downstream autonomic modulation are involved given the immediate nature of the response. 
Thus, this study examines the role of TRPA1, an irritant sensory receptor found in the 
airways, in the cardiac response of mice to acrolein and ozone.  Conscious unrestrained wild-
type C57BL/6 (WT) and TRPA1 knockout (KO) mice implanted with radiotelemeters were 
exposed once to 3 ppm acrolein, 0.3 ppm ozone, or filtered air.  Heart rate (HR) and 
electrocardiogram (ECG) were recorded continuously before, during and after exposure. 
Analysis of ECG morphology, incidence of arrhythmia and heart rate variability (HRV) were 
performed.  Cardiac mechanical function was assessed using a Langendorff perfusion 
preparation 24hrs post-exposure.  Acrolein exposure increased HRV time and frequency 
domain parameters independent of HR, as well as incidence of arrhythmia.  Acrolein also 
increased left ventricular developed pressure in WT mice at 24hrs post-exposure.  Ozone did 
not cause any changes in cardiac function in WT mice.  Neither gas caused any ECG effects 
nor was there any difference in HRV, arrhythmogenesis, or mechanical function in KO mice 
exposed to either acrolein or ozone.  These data demonstrate that a single exposure to
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 acrolein causes cardiac dysfunction through TRPA1 activation and autonomic imbalance 
characterized by a shift towards parasympathetic modulation. Furthermore, it is clear from 
the lack of ozone effects that although gaseous irritants are capable of eliciting immediate 
cardiac changes, gas concentration and properties play an important role.  
Introduction 
 Ambient air pollution has been linked to adverse cardiovascular effects by numerous 
epidemiological, human and animal studies.  Although most of the research over the last 
decade have focused on particulate matter (PM), recent data suggest gaseous pollutants likely 
contribute significantly to acute decrements in cardiac function and result in increased overall 
risk for cardiovascular dysfunction (Campen, Robertson et al. 2014, Hazari, Griggs et al. 
2014, Mills, Atkinson et al. 2015, Shah, Lee et al. 2015). In fact, the 2010 American Heart 
Association document on PM and cardiovascular disease clearly states that “Although 
PM2.5 mass has rightfully attracted attention as a target for regulation and epidemiological 
study, more than 98% of the air pollutant mass in the mixture we breathe in urban settings is 
from gases or vapor-phase compounds…”, not to mention there is still relatively little data 
describing the effects of gaseous pollutants on the cardiovascular system (Brook, 
Rajagopalan et al. 2010). Thus, more studies are needed to determine the effect of individual 
gases and their causative pathways, particularly given the mechanism underlying the 
response will undoubtedly differ for the gas alone and when combined with other pollutants 
such as PM.  
 In addition to “criteria” pollutant gases like ozone (O3) for which the United States 
Environmental Protection Agency has set National Ambient Air Quality Standards 
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(NAAQS), non-NAAQS hazardous air pollutants (HAPs) such as acrolein are also frequently 
present in ambient air pollution, particularly in emissions from combustion processes 
including exhaust from automobiles, emissions from coal-fired power plants, and emissions 
from industrial sites (CDC ToxProfile). Acrolein is a gaseous irritant formed during the 
combustion of petrochemical fuels such as gasoline or diesel and it is considered to pose the 
greatest relative HAP hazard for non-cancer health effects (EPA 1996, Haussmann 2012). To 
that point, we previously showed that a single exposure to either O3 or acrolein causes 
various cardiovascular effects in rodents; these range from electrocardiogram changes, 
autonomic imbalance, desensitization of baroreflex, to alterations in hypoxia responsiveness 
(Hazari, Haykal-Coates et al. 2009, Farraj, Hazari et al. 2012, Perez, Ledbetter et al. 2013, 
Hazari, Griggs et al. 2014).  Moreover, many of these effects appear to be latent and are only 
evident if the body is challenged or encounters a subsequent trigger (Hazari, Callaway et al. 
2012), which would suggest the underlying mechanisms involve the disruption of 
homeostatic controls which maintain equilibrium of vital bodily systems under changing 
conditions.   
 Numerous biological pathways have been described that link air pollution with 
cardiovascular dysfunction.  These include systemic inflammation and oxidative stress, 
vasoconstriction, enhanced coagulation/thrombosis, autonomic effects due to sensory 
receptor activation, and the direct effects of translocated particles on the myocardium (Brook, 
Rajagopalan et al. 2010).  Of these, airway sensory activation may be the most relevant when 
considering the short-term, reversible, and often latent effects of an acute ambient exposure. 
An examination of the role of airway sensory nerves in the body indicates that not only do 
they “sense” or become activated by specific gaseous pollutants but also cause internal 
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homeostatic changes that may predispose to respiratory and cardiovascular dysfunction (Lee 
and Pisarri 2001, Jordt and Ehrlich 2007).   
 Gaseous air pollutants such as ozone, acrolein, and other reactive aldehydes 
commonly found in combustion-derived exhaust, stimulate sensory nerves in the airways 
causing several well-described ventilatory and pulmonary effects (McDonnell, Horstman et 
al. 1983, Jordt 2011, Abbott-Banner, Poll et al. 2013, Büch, Schäfer et al. 2013). A subset of 
these responses is known to be mediated by airway sensors, particularly transient receptor 
potential cation channels A1 (TRPA1) and V1 (TRPV1), located on pulmonary C-fibers 
(Nassenstein, Kwong et al. 2008, Taylor-Clark, McAlexander et al. 2008).  It has been 
suggested that these sensors may also mediate some cardiovascular responses as well (Hazari 
et al., 2011; Jones et al., 1995; L.-Y. Lee, 2010; Wang et al., 2000) and in fact, our previous 
studies have demonstrated that pharmacological inhibition of TRPA1 attenuates air pollution-
induced cardiac arrhythmia produced by autonomic imbalance in rats (Hazari, Haykal-Coates 
et al. 2011).   
 Thus, in the present study we investigated the cardiac effects of exposure to acrolein 
or ozone inhalation with WT and TRPA1 KO mice. Acrolein was chosen because it is a 
common gaseous component of urban air pollution and a known TRPA1 activator (Bautista, 
Jordt et al. 2006). Only a single study has shown that ozone, albeit in solution and not 
inhaled, activates TRPA1 (Taylor-Clark and Undem 2010), yet its irritant properties suggest 
that such a finding is not unreasonable. Regardless, although both have been traditionally 
classified as respiratory irritants, data from the last five years have clearly shown that both 
gases not only also affect the cardiovascular system but other organ systems through 
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pathways which implicate a role for the intrinsic control mechanisms of the body (Bessac and 
Jordt 2010, DeJarnett, Conklin et al. 2014, Miller, Karoly et al. 2015). The concentration of 
acrolein used in this study was admittedly high to serve as a proof of concept but certainly 
there are extreme conditions (e.g. structural fires), occupational settings or cigarette smoke in 
which the levels of acrolein exceed those used here. Irrespective of this high concentration, 
the broader aim was to not only firmly establish a role for TRPA1 in air pollution-induced 
electrical and mechanical cardiovascular dysfunction but also clarify whether inhalation of 
acrolein and ozone produce cardiovascular effects through TRPA1. 
Materials and Methods 
Animals - Female C57BL/6 and TRPA1 -/- mice (22 ± 3.8 g) were used in this study 
(Jackson Laboratory - Bar Harbor, ME). Mice were initially housed five per cage and 
maintained on a 12-hr light/dark cycle at approximately 22°C and 50% relative humidity in 
an AAALAC–approved facility. Food (Prolab RMH 3000; PMI Nutrition International, St. 
Louis, MO) and water were provided ad libitum. All protocols were approved by the 
Institutional Animal Care and Use Committee of the U.S. Environmental Protection Agency 
and are in accordance with the National Institutes of Health Guides for the Care and Use of 
Laboratory Animals. The animals were treated humanely and with regard for alleviation of 
suffering. Background controls were used as appropriate. 
Experimental Groups - Wild-type and TRPA1 knockout mice were randomly assigned to 
one of three exposure groups: (1) Acrolein (Acrl); (2) Ozone (O3); or (3) filtered air (FA). 
There were 8-12 animals per group.  
Surgical implantation of radiotelemeters - Animals were weighed and then anesthetized 
using inhaled isoflurane (Isothesia, Butler Animal Health Supply, Dublin OH). Anesthesia 
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was induced by spontaneous breathing of 2.5% isoflurane in pure oxygen at a flow rate of 1 
L/min and then maintained by 1.5% isoflurane in pure oxygen at a flow rate of 0.5 L/min; all 
animals received the analgesic Buprenorphrine (0.03 mg/kg, i.p. manufacturer). Using 
aseptic technique, each animal was implanted subcutaneously with a radiotelemeter (ETA-
F10, Data Sciences International, St Paul, MN); the transmitter was placed under the skin to 
the right of the midline on the dorsal side. The two electrode leads were then tunneled 
subcutaneously across the lateral dorsal sides; the distal portions were fixed in positions that 
approximated those of the lead II of a standard electrocardiogram (ECG). Body heat was 
maintained both during and immediately after the surgery. Animals were given food and 
water post-surgery and were housed individually. All animals were allowed 7-10 days to 
recover from the surgery and reestablish circadian rhythms. 
Radiotelemetry data acquisition - Radiotelemetry methodology (Data Sciences 
International, Inc., St. Paul, MN) was used to track changes in cardiovascular function by 
monitoring heart rate (HR), and ECG waveforms immediately following telemeter 
implantation, through exposure until 24 hours post-exposure. This methodology provided 
continuous monitoring and collection of physiologic data from individual mice to a remote 
receiver. Sixty-second ECG segments were recorded every 5 minutes during the pre- and 
post-exposure periods.  ECG was recorded continuously during exposure (baseline and hours 
1-4); HR was automatically obtained from the waveforms (Dataquest ART Software, version 
3.01, Data Sciences International, St. Paul, MN, USA). 
Electrocardiogram (ECG) analysis - ECGAuto software (EMKA Technologies USA, Falls 
Church VA) was used to visualize individual ECG waveforms, analyze and quantify ECG 
segment durations and areas, as well as identify cardiac arrhythmias as previously described 
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(Hazari, Haykal-Coates et al. 2009). Briefly, using ECGAuto, P-wave, QRS complex, and T-
wave were identified for individual ECG waveforms and compiled into a library. Analysis of 
all experimental ECG waveforms was then based on established libraries. The following 
parameters were determined for each ECG waveform: PR interval (Pstart-R), QRS complex 
duration (Qstart-S), ST segment interval (S-Tend) and QT interval (Qstart-Tend). QT interval was 
corrected for HR using the correction formula for mice QTc = QT/(RR/100)1/2  (Mitchell, 
Jeron et al. 1998). All ECG streams with less than 10 s of identifiable cardiac cycles were 
excluded from ECG parameter calculations. Figure 2 shows a typical ECG trace as well as 
examples of the types arrhythmia observed in this study. 
HRV Analysis - Heart rate variability (HRV) was calculated as the mean of the differences 
between sequential RRs for the complete set of ECG waveforms using ECGAuto. For each 
1-min stream of ECG waveforms, mean time between successive QRS complex peaks (RR 
interval), mean HR, and mean HRV-analysis–generated time-domain measures were 
acquired. The time-domain measures included standard deviation of the time between 
normal-to-normal beats (SDNN), and root mean squared of successive differences (RMSSD). 
SDNN represents overall HRV, while RMSSD represents parasympathetic influence over 
HRV. Analysis of HRV was also conducted in the frequency domain using a fast-Fourier 
transform. For frequency domain analysis, the signal was analyzed with a Hamming window 
for segment lengths of 512 samples with 50% overlapping. The spectral power obtained from 
this transformation represents the total harmonic variability for the frequency range being 
analyzed. In this study, the spectrum was divided into low-frequency (LF) and high-
frequency (HF) regions with frequency bands assigned as 0.15-1.5 and 1.5-5 Hz respectively. 
LF is generally believed to represent a combination of sympathetic and parasympathetic 
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activity, while HF indicates cardiac parasympathetic (vagal) activity (Ori, Monir et al. 1992).  
All ECG streams with less than 1 min of identifiable RR intervals were excluded from HRV 
analysis. Additionally thorough visual inspection was conducted to identify and exclude 
arrhythmias and artifacts.  
Exposure – The study protocol included two days of animal-to-chamber acclimatization 
prior to exposure. Three or four hour exposures to acrolein or ozone respectively (Exposure) 
started with 30 min of additional chamber acclimatization. All mice were moved back to 
their home-cages after the exposure (Post-exposure) and monitored for 24 hours (Post-
exposure 24hr+) before necropsy. 
Ozone exposure – Ozone (O3) exposures took place in whole-body exposure chambers.  O3 
was generated by passing extra dry oxygen past an arcing transformer in a model V5-0 ozone 
generator (Ozone Research & Equipment Corp., Phoenix, AZ). The chamber concentrations 
(0.3 ppm) were controlled by the computer program DASYLab (version 9.0; DasyTec USA, 
Amherst, NH), which controlled the opening and closing of a mass flow controller at each 
chamber. Ozone concentrations were monitored using continuous gas analyzers (model 49i, 
model 49, Thermo Fisher Scientific, Foxfire, MA), which fed a signal to a proportional, 
integral, derivative loop control, which then either opened or closed the mass flow controller 
to maintain the O3 concentration in the chamber at the desired level. Filtered air control 
exposures were simultaneously conducted with all chamber conditions maintained and O3 
levels < 0.010 ppm 
Acrolein exposure – Acrolein exposures took place in whole-body plethysmography 
chambers (Model PLY3213, Buxco Electronics, Inc., Wilmington, NC, USA. Acrolein gas 
was metered from a 1,000 ppm cylinder into a glass mixing chamber where the gas was 
70 
mixed and diluted with dry filtered air to achieve a final concentration of 3 ppm of acrolein 
with a total flow of 6 L/min. The actual chamber concentration was measured once per hour 
using an HP5890 gas chromatograph (GMI Inc., Ramsey, MN, USA) equipped with manual 
injection, a flame ionization detector and a DB-VRX capillary column. 
Cardiac Perfusion - The procedure for cardiac perfusion has been previously described 
(Tong et al. 2010). Briefly, 24 hours after exposure, mice were anesthetized with sodium 
pentobarbital (80 mg/kg, i.p.). Heparin (100 units) was injected intravenously before removal 
of heart. The hearts were rapidly removed and placed in ice-cold Krebs-Henseleit buffer, 
after which the aortas were cannulated. Retrograde perfusion via the aorta was performed 
under constant pressure (100 cmH2O) above the heart. The non-recirculating perfusate was a 
Krebs-Henseleit buffer containing (in mmol/L) 120 NaCl, 5.9 KCl, 1.2 MgSO4, 1.75 CaCl2, 
25 NaHCO3, and 11 glucose. The buffer was aerated with 95% O2—5% CO2 and maintained 
at pH 7.4 and a temperature of 37°C. 
 For assessment of contractile function, a latex balloon on the tip of a polyethylene 
catheter was inserted through the left atrium into the left ventricle. The catheter was 
connected to a pressure transducer (Argon Medical Devices, Athens, TX) at the same height 
as the heart. The pressure of the left ventricular balloon was inflated to 0-5 cmH2O. A 
PowerLab system was used to collect and process the heart rate, left ventricular developed 
pressure (LVDP), and contractility (dP/dt) data (AD Instruments, Milford, MA). All hearts 
were perfused for 25 min; we then initiated 20 min of global no-flow ischemia by stopping 
the flow of oxygenated perfusion buffer, followed by 1 hr of reperfusion. Onset of ischemic 
contracture was measured as the time from the start of ischemia until initial contracture (at 
least 5 cmH2O increase in left ventricular pressure). Recovery of LVDP, expressed as a 
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percentage of the initial pre-ischemic LVDP, was measured at 20, 40 and 60 min of 
reperfusion after 20 min of ischemia.  
Statistics - All data are expressed as means ± SEM. Statistical analyses of the data were 
performed with GraphPad Prism 5 (GraphPad software, San Diego CA). A minimum power 
of 0.8 was used to determine sample size. For HR, ECG intervals and HRV, two-way 
analysis of variance (ANOVA) for repeated-measures and Bonferroni post hoc tests were 
used to determine statistical differences. A one-way ANOVA was used to analyze arrhythmia 
counts. For Langendorff cardiac perfusion data, comparisons between groups were 
performed by one-way ANOVA followed by Bonferroni post hoc test for multiple 
comparisons. Comparisons were made across all groups taking into account the multiple 
endpoints, exposure groups and time points as well as any interactions. 
Results 
Heart Rate – Table 1 lists the average heart rates before, during and after exposure.  The 
Pre-exposure period represents a 4 hr time-matched period one day before exposure.  The 
Post-exposure period represents the 4 hrs directly following exposure, and the 24 hr Post-
exposure represents a 4 hr time-matched period one day after exposure.  All animals 
experienced an increase in HR when initially placed in the exposure chamber and all 
progressively decreased over the course of the exposure.  There were no significant 
differences in HR within the strains among any of the exposure groups during any time 
period, however the WT animals demonstrated a more robust increase in HR in every 
exposure group compared with the KO animals.  Exposure to ozone did produce a decrease 
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in HR in the KO animals compared with the pre-exposure period and compared with ozone-
exposed WT animals. 
Electrocardiogram (ECG) - Table 2 shows the ECG parameters before, during and after 
exposure. There were no significant differences in ECG interval durations between animals 
exposed to acrolein or ozone compared with filtered air during any time period. When 
compared to the pre-exposure period, WT animals had no significant changes in ECG 
interval durations during the exposure period. In contrast, KO mice demonstrated slight 
increases in QRS and QTc interval lengths during acrolein, ozone, and filtered air exposure 
indicating that these were likely a physiological response of the KOs to placement in the 
exposure chamber rather than a response to the pollutant.   
Heart Rate Variability (HRV) - Exposure to acrolein caused significant increases in all 
measures of HRV in WT animals, including the time domain measurements SDNN and 
RMSSD (Figure 1A and B), as well as the high and low frequency domain measurements 
(Figure 1C and D) when compared with filtered air and KO mice. There was no effect of 
acrolein on KO mice nor was there any effect of ozone exposure on either WT or KO mice.  
Cardiac arrhythmia - Typical ECG and cardiac arrhythmia observed in mice exposed to 
acrolein and ozone are shown in Figure 2. There was a significant increase in the number of 
arrhythmia during the 3 hour exposure period to acrolein (27.8 ± 10.8) when compared with 
filtered air (2.2 ± 0.9) (Figure 3).  No other significant differences in arrhythmias were 
observed between any exposure groups at any time period. 
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Cardiac mechanical effects - Post-exposure (pre-ischemic) and post-ischemic left 
ventricular pressure measurements are summarized in Table 3.  Exposure to acrolein 
significantly increased LVDP 24 hrs post-exposure (129.9 ± 10.3 cm H20) compared with 
filtered air-exposed controls (86.4 ± 7.8 cm H20) (Figure 4)  There were no other significant 
differences in cardiac mechanical function between any other groups at any other time points. 
Discussion 
 The results of this study demonstrate that TRPA1 channels found on airway sensory 
nerves, which can be described as sensors for a broad array of environmental irritants, play a 
role in the cardiovascular response of mice to acrolein. The data presented here also suggests 
that a single exposure to air pollution causes not only cardiac electrical disturbances, which 
are commonly observed in humans (Peters, Liu et al. 2000), but acute, nearly imperceptible 
changes in cardiac mechanical function as well; these findings corroborate not only our 
previous work (Kurhanewicz, McIntosh-Kastrinsky et al. 2014) but the work of others (Tong, 
Cheng et al. 2010). More importantly, the current study confirms that gaseous air pollutants 
have effects beyond the respiratory system affecting not only cardiac function but also the 
homeostatic control of the cardiovascular system as indicated by changes in HRV. In order to 
elucidate how gaseous air pollutants may cause this cardiac dysfunction, we investigated the 
role of TRPA1 by using high concentrations of acrolein as a putative positive control and 
lower concentrations of ozone as a more relevant and real-world exposure. Acrolein 
produced abnormal modulation of autonomic balance and an increased incidence of 
arrhythmia through TRPA1, which also mediated an increase in LVDP. In contrast, exposure 
to ozone did not appear to cause any significant effects despite the fact that mild 
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cardiovascular effects of ozone at similar levels have been documented by our lab in the past 
and by others (Wu, Kuo et al. 2010, Farraj, Hazari et al. 2012, Barath, Langrish et al. 2013, 
Wang, Jiang et al. 2013, Kurhanewicz, McIntosh-Kastrinsky et al. 2014, Farraj, Walsh et al. 
2015). 
 Sensory receptors in the respiratory system, from the nose down to the lower lungs, 
respond to gaseous irritants and initiate visceral (i.e. autonomic) reflexive changes which 
impact the function of the cardiovascular system. While it is unlikely that inhalation of these 
gases affects the heart or vasculature by causing direct toxicity or damage, there is certainly 
enough data that suggests signals initiated in the airways can lead to altered cardiovascular 
regulation, compensatory deficits, and increased sensitivity to subsequent exposures 
(Widdicombe and Lee 2001). Thus, these irritant gases may not be overtly deleterious but 
rather may increase the risk of an adverse response if another stressor is encountered and the 
body is unable to maintain homeostasis. We previously showed that acrolein exposure 
increases risk by desensitizing the baroreflex (Hazari, Griggs et al. 2014), which maintains 
blood pressure, and therefore systemic perfusion, by altering heart rate. As such, the 
baroreflex, as an internal sensor of blood pressure, operates and exerts its effects through the 
sympathetic and parasympathetic branches of the autonomic nervous system. Therefore any 
exposure-related changes in autonomic balance, which can be measured through HRV, 
would result in altered, and possibly impaired, regulation of the cardiovascular system. 
Although yet unsubstantiated, TRPA1 activation by acrolein may represent the initiating 
event for this baroreflex desensitization given it leads to autonomic imbalance as we have 
shown here.   
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 While the results from this study do not provide direct evidence of serious cardiac 
morbidity or premature mortality as a result of acute exposure to airway irritants, they may 
reflect a transient instability that can worsen if exposure continues over a longer period. 
Moreover, such dysregulation in individuals with pre-existing regulatory issues or disease 
resulting in poor compensatory capacity could be more seriously impacted. Performing 
studies in at-risk humans is problematic, so as a result these fundamental relationships in 
autonomic cardiac dysfunction may only be dissected in rodent models. As data examining 
autonomic function in rodents in the past had to be interpreted cautiously due to the use of 
anesthesia, the current results were produced from conscious unrestrained mice that could be 
monitored continuously during exposure, thus improving discernibility of toxicological 
effects relevant to human scenarios. Still, HRV data in rodents is not easily interpretable 
given that several dynamic factors contribute to it (Rowan, Campen et al. 2007).  
 Exposure to acrolein produced significant increases in SDNN, RMSSD, LF power 
and HF power in WT mice; this response was not present in acrolein-exposed TRPA1 KO 
animals. While decreased HRV is commonly accepted as an indicator of heightened 
cardiovascular risk in humans (Gold, Litonjua et al. 2000), increased HRV has also been 
linked to adverse cardiovascular outcomes (Stein, Domitrovich et al. 2005). Indeed, other 
reports note increased HRV as an indicator of heightened risk. For example, increased 
RMSSD has been shown to be associated with elevated risk of air pollution-induced 
arrhythmia (Davoodi, Sharif et al. 2010) and increases in HRV have been demonstrated 
preceding post-operative atrial fibrillation (Amar, Zhang et al. 2003).  Additionally, increases 
in vagal tone have been associated with adverse cardiovascular events in type II diabetics 
(Eguchi, Schwartz et al. 2010), and linked with increased mortality in heart failure patients 
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and the elderly (de Bruyne, Kors et al. 1999, Stein, Domitrovich et al. 2005).  With regard to 
the animal models, we have consistently shown that exposure to different types of air 
pollutants such as residual oil fly ash (Farraj, Hazari et al. 2011, Carll, Haykal-Coates et al. 
2015), diesel exhaust (Hazari, Haykal-Coates et al. 2011, Carll, Lust et al. 2013), ozone 
(Farraj, Hazari et al. 2012) and acrolein (Hazari, Griggs et al. 2014) all lead to an increase in 
HRV in rodent models. This is not entirely surprising given increased HRV, and in particular 
RMSSD and HF, indicate parasympathetic modulation which is a well-characterized reflex 
response to airway sensory activation (Lee and Pisarri 2001).  Thus, it is clear the 
relationship between HRV and cardiac dysfunction cannot be overly simplified to say 
increased HRV is good whereas decreased HRV is bad. Instead, it is the imbalance of this 
homeostatic mechanism, regardless of direction of change, which likely produces the 
increase in risk. In fact, the presence of simultaneous electrical disturbances in the ECG may 
further indicate the underlying shift from normal function.   
 In our studies, increased HRV, and therefore parasympathetic modulation, was 
observed with an increased incidence of sinus node dysfunction and dysrhythmia (Figure 2) 
during acrolein exposure in normal animals.  Increased vagal tone can cause such changes in 
the P-wave to P-wave interval independent of normal breathing. This condition is known as 
non-respiratory sinus arrhythmia and it differs from respiratory sinus arrhythmia (RSA) in 
that it is not associated with respiration but rather occurs when the outflow of 
parasympathetic tone predominates over sympathetic tone (Deboor, Pelter et al. 2005, 
McMullen, Whitehouse et al. 2012) and unlike RSA is grossly irregular. Furthermore, non-
respiratory sinus arrhythmia or dysrhythmia when observed with sinus node dysfunction can 
indicate sick sinus syndrome (Keller and Lemberg 2006), which is a group of abnormal heart 
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rhythms that appear not only as a blocked sinus signal but also as random intervals of 
bradycardia and tachycardia. Although these parameters fit what we observed with acrolein, 
it still remains to be determined whether it represents a toxicological effect that leads to 
adverse systemic outcomes; yet it would not be unreasonable to suspect that such a change 
might predispose an individual to subsequent triggered responses. Increases in HRV 
associated with increased randomness of the heart rate, that is, a high degree of non-
respiratory sinus arrhythmia have been found to be strongly associated with risk of mortality 
(Stein 2004, McMullen, Whitehouse et al. 2012).  
 Interpreting the frequency domain of the HRV data is a bit more challenging.  The 
cardiac cycle and R-R interval variability are affected by multiple control mechanisms 
including autonomic modulation at the SA node, the dynamic regulation of the vasculature, 
as well as endocrine/paracrine, endothelial and mechanical factors.  Additionally, complex 
control mechanisms including baroreflex and respiratory sinus arrhythmia can also drive 
changes in these parameters. Numerous studies have shown that the HF power component of 
HRV is strongly associated with cardiovagal activity (Chess, Tam et al. 1975, Piccirillo, 
Ogawa et al. 2009, Billman 2013, Heathers 2014).  In contrast, there is a growing body of 
evidence directly countering the claim that LF power is proportional to cardiac sympathetic 
nerve activity (Goldstein, Bentho et al. 2011, Billman 2013, Reyes del Paso, Langewitz et al. 
2013).  In fact, a number of studies suggest that LF power may better reflect other 
mechanisms exerting regulatory control over the cardiac cycle such as baroreflex activity in 
response to vasomotor tone (Moak, Goldstein et al. 2007, Goldstein, Bentho et al. 2011, 
Rahman, Pechnik et al. 2011). Investigators have also used LF/HF, which was popularized in 
the 1980’s, as a measure of sympatho-vagal balance (Pagani, Lombardi et al. 1984), however 
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more recent analysis of this metric has cast doubt on its interpretation (Billman 2013, Reyes 
del Paso, Langewitz et al. 2013, Heathers 2014).  Although the two branches of the 
autonomic nervous system may act reciprocally, they can also be co-activated or completely 
uncoupled and function independently of one-another (Amar, Zhang et al. 2003, Reyes del 
Paso, Langewitz et al. 2013).  Thus, the HF and LF power measurements may provide 
information relating to different physiological control mechanisms. Namely that HF power 
may be more strongly related to vagal influence while LF may provide information about a 
mix of sympathetic and other factors such as blood pressure control mechanisms including 
modulation of vasomotor tone, but with parasympathetic factors accounting for the largest 
portion of the variability in this frequency range (Billman 2013, Reyes del Paso, Langewitz 
et al. 2013).   
 Notably, in this study exposure to ozone produced no discernable adverse cardiac 
effects in either WT or KO mice. While these results corroborate both our previous findings 
and those of others (Wu, Kuo et al. 2010, Farraj, Hazari et al. 2012, Barath, Langrish et al. 
2013, Wang, Jiang et al. 2013, Farraj, Walsh et al. 2015) they also highlight the fact that the 
cardiovascular response to low level or near-ambient ozone is quite variable and requires 
further investigation. We assumed a role for TRPA1 given the findings of Taylor-Clark and 
Undem (Taylor-Clark and Undem 2006)2006) who showed activation of TRPA1 on airway 
C-fibers by high concentrations of ozone in an ex-vivo system. Therefore, the lack of 
discernable effects in this study may be due to the lower concentrations of ozone applied in 
our study as well as differences intrinsic to the in-vivo system which would certainly have 
changed the exposure profile (i.e. presence of epithelium, lining fluid, etc). To that point, the 
activity level of the subjects also contributes to the dose of ozone received as exercise has 
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been shown to increase the dose of ozone delivered to the lungs (Hatch, Slade et al. 1994).  
In this study, where the mice were primarily at rest, the effective dose of ozone delivered to 
the lower airways would be relatively low. Additionally, phenotypic differences between the 
subtypes of C-fibers being targeted by acrolein and ozone may also account for some of the 
differences observed in our responses. Acrolein is known to primarily impact the upper 
airways and not penetrate much past the larynx while ozone can reach deep into the lung. As 
such, C-fibers demonstrate phenotypic differences in their sensitivities and responses to 
chemical and mechanical stimuli based on location (Lee and Pisarri 2001) (Coleridge and 
Coleridge 1984). Hence, differences in activation of C-fiber subtypes may account for the 
disparate responses observed. 
 Our study demonstrates that autonomic nervous system function can be modulated by 
TRPA1, and appears to also play a role in the acrolein-induced cardiac arrhythmia and 
mechanical changes. Stimulation of the nasal or laryngeal mucosa with an irritant such as 
acrolein has been shown to cause a slowing of the HR in combination with an irregular 
rhythm (Kratschmer 2001), however there are very little data demonstrating a link between 
airway irritation and cardiac dysrhythmia. TRPA1 activation increases the release of 
glutamate, a centrally-acting neurotransmitter that facilitates transmission in the nucleus 
tractus solitarius (Sun, Bang et al. 2009). Although yet unproven, it is conceivable that this 
modulation of central neurotransmission can result in autonomic modulation and altered 
cardiovascular function. Similar mechanisms have already been demonstrated in models of 
cigarette smoke irritation (Mutoh, Joad et al. 2000) as well as others (Paton and Nolan 2000, 
Simms, Paton et al. 2006), while TRPA1’s role in modulating other “autonomic” activity 
(e.g. breathing) in the brainstem is also known (Tani, Yazawa et al. 2015). TRPA1 also 
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appears to play a role in the increase in LVDP 24hrs after exposure. We have also shown 
myocardial dysynchrony and increased left ventricular stroke volume in C57BL/6 mice 24hrs 
after acrolein. Similarly, Tong et al. (Tong, Cheng et al. 2010) showed a trend toward 
increasing LVDP after particulate matter exposure. It is possible that the increase in LVDP 
observed here is a compensatory response to increased stroke volume to maintain cardiac 
output  
Conclusion 
 We showed here that a single acute exposure to acrolein disrupts normal autonomic 
balance and produces arrhythmia in healthy, young mice. Disruption of autonomic 
homeostasis can increase the risk of subsequent adverse cardiovascular events as was seen 
here with the increased incidence of arrhythmia. Acute exposure to airway irritants may not 
cause overt functional effects, but rather may produce latent or subclinical effects that are 
only manifested when the host is challenged by a subsequent stressor or disease state. 
However, the likelihood of this occurring clearly depends on not only the level (i.e. 
concentration, duration, etc) of exposure, but the characteristics of the pollutant as well. The 
underlying health of the host must also be considered because the greatest risk may be in 
subjects with eroded or impaired compensatory capacity as is seen with chronic respiratory 
and cardiovascular disease. Despite a somewhat better understanding of this mechanism, all 
of these factors must be accounted for if a proper assessment of risk is to be made.   
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Tables and Figures 
Table 1. The Effect of Acrolein or Ozone Exposure on Heart Rate 
WT Filtered Air Acrolein Ozone 
Pre-exposure 575.9 ± 19.5 607.3 ± 34.4 563.1 ± 11.3 
Exposure 617.1 ± 9.9 638.3 ± 6.6 626.6 ± 10.5 
Post-exposure 546.5 ± 13.2 573.5 ± 7.1 548 ± 9.8 
24hr Post-exposure 525.9 ± 14.2 552.4 ± 14.7 540.3 ± 8.8 
KO    
Pre-exposure 570.9 ± 19.3 575 ± 16.2 573.3 ± 9.6 
Exposure 587.9 ± 14.3 600.8 ± 12.6 562.2 ± 20.7 †‡ 
Post-exposure 584.8 ± 15.8 607.5 ± 9.5 594.8 ± 13.4 
24hr Post-exposure 552.5 ± 17 573.2 ± 15.4 571.5 ± 9.4 
Values are mean (beats/min) ± SEM. *p < 0.05; significantly different from FA. †p < 0.05; 
significantly different from Pre-exposure period. ‡p < 0.05; significantly different from WT 
strain. (n=8-12) 
 
Table 2. The Effect of Acrolein or Ozone Exposure on Electrocardiogram Parameters 
PR (msec) 
WT Filtered Air Acrolein Ozone 
Pre-exposure 35.16 ± 0.59 32.65 ± 0.51 34.14 ± 0.74 
Exposure 37.02 ± 0.4 34.33 ± 0.73 35.26 ± 0.58 
Post-exposure 35.34 ± 0.54 32.82 ± 0.52 34.25 ± 0.59 
KO       
Pre-exposure 30.34 ± 0.65 29.35 ± 0.35 30.17 ± 0.69 ‡ 
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Exposure 30.95 ± 0.77 31.36 ± 0.75 ‡ 31.97 ± 0.75 ‡ 
Post-exposure 32.33 ± 0.98 31.84 ± 0.75 32.75 ± 0.74 
QRS (msec) 
WT Filtered Air Acrolein Ozone 
Pre-exposure 13.41 ± 0.52 11.9 ± 0.08 12.45 ± 0.3 
Exposure 12.4 ± 0.35 11.14 ± 0.28 12.23 ± 0.18 
Post-exposure 13.28 ± 0.48 11.74 ± 0.02 12.34 ± 0.28 
KO       
Pre-exposure 11.96 ± 0.34 12.43 ± 0.31 11.66 ± 0.25 
Exposure 13.64 ± 0.56 † 14.21 ± 0.58  †‡ 13.45 ± 0.5 † 
Post-exposure 11.78 ± 0.35 12.39 ± 0.33 11.71 ± 0.36 
QTc (msec) 
WT Filtered Air Acrolein Ozone 
Pre-exposure 74.58 ± 3.07 65.94 ± 2.08 71.58 ± 2.69 
Exposure 67.98 ± 2.14 68.1 ± 1.73 69.39 ± 1.34 
Post-exposure 73.93 ± 3.93 63.36 ± 2.15 69.95 ± 2.95 
KO       
Pre-exposure 72.38 ± 1.18 71.81 ± 1.34 72.58 ± 3.11 
Exposure 82.91 ± 3.39 †‡ 84.74 ± 4.07 †‡ 81.93 ± 4.02 †‡ 
Post-exposure 67.68 ± 1.76 70.18 ± 1.21 67.29 ± 2.38 
Values are mean ± SEM. *p < 0.05; significantly different from FA. †p < 0.05; significantly 
different from Pre-exposure period. ‡p < 0.05; significantly different from WT strain. (n=8-
12) 
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Table 3. Cardiac Mechanical Effects of Exposure to Acrolein or Ozone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
dP/dtmax = maximum 1
st derivative of the change in left ventricular pressure/time; dP/dtmin = 
minimum 1st derivative of the change in left ventricular pressure/time.  Values are mean ± 
SEM. *p < 0.05; significantly different from FA (n=8-12) 
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Table 4. Summary of Exposure Effects 
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Figure 1. Exposure to acrolein but not ozone increases all measures of HRV. WT mice 
experienced an increase in SDNN, RMSSD, LF/HF, LF and HF during exposure to acrolein.  
These increases in HRV were not observed in TRPA1 KO animals. There was no effect of 
ozone exposure on either the WT or KO animals. Values are mean ± SEM. *p < 0.05; 
significantly different from FA. ‡p < 0.05; significantly different from KO strain. (n=8-12) 
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Figure 2. Typical Electrocardiogram and Cardiac Arrhythmia in Mice Exposed to Acrolein 
and Ozone. A. Typical mouse ECG during normal sinus rhythm. B. Dysrhythmia 
characterized by brief periods of bradycardia dispersed between periods of normal heart rate. 
C. Sino-atrial node dysfunction characterized by elongation of the R-R interval and loss of 
discernable p-waves. D. Non-conducted p-waves, which represent a loss of conduction from 
the atria to the ventricles.  All of these arrhythmia are typical of vagal dominance. 
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Figure 3. Exposure to acrolein increases cardiac arrhythmias in wildtype mice. WT mice 
experienced an increase in arrhythmia during exposure to acrolein.  Values are total number 
of arrhythmia occurances during the pre-exposure, exposure and post-exposure periods.  
There were no significant differences in arrhythmia counts between any of the groups during 
any other period. *p < 0.0001; significantly different from FA. ‡p < 0.0001; significantly 
different from KO strain (n=8-12) 
 
Figure 4. Exposure to acrolein increases left ventricular developed pressure 24hrs post-
exposure. WT animals exposed to acrolein experienced an increase in LVDP 24hrs post-
exposure when compared to FA controls.  Exposure to ozone did not produce any changes in 
LVDP. *p < 0.05; significantly different from FA (n=8-12)
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CHAPTER IV:  EXPOSURE TO ACROLEIN PRODUCES CARDIAC EFFECTS 
MEDIATED BY PARASYMPATHETIC DOMINANCE BUT ALSO SYMPATHETIC 
MODULATION IN MICE 
 Numerous studies show that short-term air pollution exposure modulates heart rate 
variability (HRV). HRV is a marker of autonomic influence on the heart and represents 
homeostatic control mechanisms which dynamically regulate cardiovascular function.  Our 
previous studies show that a single exposure to air pollution increases HRV and produces 
arrhythmia in wild-type mice in a manner implicating autonomic imbalance.  In addition, 
these changes appeared to be mediated through the airway irritant sensor TRPA1. Thus, the 
goal of this study was to characterize the autonomic changes due to exposure as reflected by 
HRV in both wild-type and knockout mice. We hypothesized that pharmacological inhibition 
of the parasympathetic and sympathetic effects on the heart would block the cardiac response 
to air pollution in wild-type mice, and that TRPA1 knockout mice would demonstrate neither 
modulated HRV nor cardiovascular dysfunction. Conscious, unrestrained C57BL/6 and 
TRPA1 knockout mice were exposed to 3 ppm acrolein for 3 hours. Immediately prior to 
exposure separate cohorts were treated with either atropine (2 mg/kg) or atenolol (2 mg/kg) 
to block the parasympathetic or sympathetic influence on the heart, respectively, 
hexamethonium (80 mg/kg) to block both, or saline. Electrocardiogram (ECG) and HR were 
recorded continuously before, during and after exposure.  Prior to exposure treatment with 
atenolol decreased HR but had no effect on any measure of HRV.  Treatment with atropine 
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increased HR and decreased SDNN.  Treatment with hexamethonium decreased both HR and 
SDNN.  Exposure to acrolein produced significant increases in SDNN, RMSSD and LF 
measures of HRV, as well as an increase in arrhythmia in WT mice.  TRPA1 KO mice did 
not demonstrate any increases in HRV with exposure to acrolein, however there was a minor 
increase in arrhythmia.  Treatment with atenolol reduced this response while treatment with 
atropine enhanced it.  Treatment with hexamethonium blunted the acrolein-induced increases 
in HRV. Treatment with all three pharmacological agents blocked the acrolein-induced 
increase in arrhythmia.  A generalized stress response in early exposure and pharmacological 
wash-out near mid-exposure compounded the complexity of this analysis.  However it is 
clear from these data that acute exposures to air pollution, which may not cause observable 
symptoms, can disrupt normal autonomic balance in healthy young animals and that while 
these changes are characterized by parasympathetic dominance, sympathetic modulation also 
appears to play a role 
Introduction 
 Autonomic reflex arcs activated by sensory receptors in the airways are believed to 
mediate some of the acute cardiovascular effects of air pollution.  In relation to this, there is 
evidence to suggest that 1) nociceptive nerve fibers in the airways are activated by irritant 
gaseous components of ambient  air pollution  (Bessac & Jordt 2010), 2) activation of these 
fibers produces afferent signaling to the brainstem and activity in specific areas known to 
play a role in the regulation of cardiovascular and ventilatory function (Mutoh, Bonham, et 
al. 2000; Bonham et al. 2006), and 3) modulation of efferent autonomic activity in the 
brainstem occurs as a result of neuropeptide release and can persist for some time after the 
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initial stimulation (i.e. plasticity)(Carr & Undem 2003; Bonham et al. 2001).  In fact, we 
previously demonstrated that the airway irritant receptor transient receptor potential A1 
channel (TRPA1) mediates cardiac arrhythmia through autonomic modulation one day after 
diesel exhaust exposure (Hazari, Callaway, Winsett, Lamb, Haykal-coates, et al. 2012). 
Similarly, altered heart rate variability (HRV) and cardiac function during acrolein exposure 
was abolished using TRPA1 knockout mice further confirming the link between sensory 
activation and altered autonomic modulation (Chapter II). 
 Numerous biological pathways have been described that link air pollution with 
cardiac dysfunction, including systemic inflammation and oxidative stress, vasoconstriction, 
enhanced coagulation/thrombosis, autonomic effects due to sensory receptor activation, and 
the direct effects of translocated particles on the myocardium (Simkhovich et al. 2008; Lee & 
Widdicombe 2001); of these, airway sensory activation resulting in changes in autonomic 
nervous system function may be the most relevant when considering the short-term, 
reversible, and often latent effects of an acute exposure.  In fact, epidemiological studies 
have repeatedly shown that exposure to air pollution causes changes in HRV (Gold et al. 
2000; Pope et al. 1999), which is an indicator of autonomic influence on the heart. Yet, data 
characterizing HRV changes during exposure are limited, particularly focused examinations 
of the relative influence of the parasympathetic and sympathetic branches which dynamically 
control cardiac function on a beat-by-beat basis. The results of this study will address some 
of those questions and fill the data gaps related to HRV responses during exposure, 
particularly as they relate to TRPA1 and irritant-induced activation in the airways.  
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 HRV is often used to address the influence of the autonomic nervous system on the 
heart.  It is an indirect measure which represents input from homeostatic control mechanisms 
that regulate, among other things, cardiovascular and respiratory function (Anon 1996).  As 
such, the cardiac cycle and R-R interval variability are continuously adjusted by multiple 
controls including the modulation of autonomic outflow at the sinoatrial (SA) node, the 
dynamic regulation of the vasculature, as well as endocrine/paracrine, endothelial and 
mechanical factors.  Additionally, dynamic mechanisms like baroreflex, which monitors 
blood pressure changes, chemoreflex, which measures oxygen and carbon dioxide in the 
body, and respiratory sinus arrhythmia, which originates from the cyclical changes in 
thoracic pressure during breathing, can also drive changes in HRV. Despite this complexity, 
several measures of HRV have been shown to correlate with modulation of one or both arms 
of the autonomic nervous system and thus indicate changes in the neural inputs to the heart 
 Thus, the current study focuses on the role of the parasympathetic and sympathetic 
branches of the autonomic nervous system in HRV, which is still not completely 
characterized in mice. In particular, it is not always clear whether a given response is related 
to the normal dynamic tendency of HRV or if it is actually an exposure-induced effect. In 
addition, the fluctuation of autonomic influences on the heart during an air pollution 
exposure have not been delineated. This is particularly important given certain changes in 
HRV have been strongly associated with increased cardiovascular risk. Whether this relates 
to an increased level of sympathetic influence due to the environmental stressor or vagal (i.e. 
parasympathetic) dominance because of irritant activation in the airways remains to be 
determined. Hence, in this study, pharmacological blockade was used to determine the 
relative contribution of the parasympathetic and sympathetic branches to HRV changes 
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observed during acrolein exposure. We hypothesized that pharmacological blockade of 
parasympathetic neurotransmission would block the HRV effects of acrolein in mice. 
Ventilatory function was also measured during exposure to get a general idea of the acrolein 
effects on breathing and whether they may affect HRV.  
Materials and Methods 
Animals - Female C57BL/6 (21 ± 1.1 g)  and TRPA1 -/- mice (27 ± 3.8 g) between 15 and 
30 weeks old were used in this study (Jackson Laboratory - Bar Harbor, ME). Mice were 
initially housed five per cage and maintained on a 12-hr light/dark cycle at approximately 
22°C and 50% relative humidity in an AAALAC–approved facility. Food (Prolab RMH 
3000; PMI Nutrition International, St. Louis, MO) and water were provided ad libitum. All 
protocols were approved by the Institutional Animal Care and Use Committee of the U.S. 
Environmental Protection Agency and are in accordance with the National Institutes of 
Health Guides for the Care and Use of Laboratory Animals. The animals were treated 
humanely and with regard for alleviation of suffering. Background controls were used as 
appropriate.  
Experimental Groups and Pharmacological Agents - Wild-type and TRPA1 knockout 
mice were randomly assigned to one of four pharmacological treatment groups: (1) Saline 
vehicle (0.9% sodium chloride), (2) Atropine (2 mg/kg), (3) Atenolol (2 mg/kg), or (3) 
Hexamethonium chloride (80 mg/kg). All drugs were purchased from Sigma-Aldrich, St. 
Louis MO. There were 6 animals per group.  Animals were pre-treated a total of 3 times prior 
to exposure (days -14, -10, -7) to assure they were responding predictably and reproducibly 
to pharmacological agents, then given a week in order to avoid possible complications due to 
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habituation to the drug and for any residual effects of the drugs to wear off.  On day 0 
animals were treated immediately prior to filtered air exposure, and on day 1 animals were 
treated immediately prior to acrolein exposure. 
Surgical implantation of radiotelemeters - Animals were weighed and then anesthetized 
using inhaled isoflurane (Isothesia, Butler Animal Health Supply, Dublin OH). Anesthesia 
was induced by spontaneous breathing of 2.5% isoflurane in pure oxygen at a flow rate of 1 
L/min and then maintained by 1.5% isoflurane in pure oxygen at a flow rate of 0.5 L/min; all 
animals received the analgesic Buprenorphrine (0.03 mg/kg, i.p. manufacturer). Using 
aseptic technique, each animal was implanted subcutaneously with a radiotelemeter (ETA-
F10, Data Sciences International, St Paul, MN); the transmitter was placed under the skin to 
the right of the midline on the dorsal side. The two electrode leads were then tunneled 
subcutaneously across the lateral dorsal sides; the distal portions were fixed in positions that 
approximated those of the lead II of a standard electrocardiogram (ECG). Body heat was 
maintained both during and immediately after the surgery. Animals were given food and 
water post-surgery and were housed individually. All animals were allowed two weeks to 
recover from the surgery and reestablish circadian rhythms. 
Radiotelemetry data acquisition - Radiotelemetry methodology (Data Sciences 
International, Inc., St. Paul, MN) was used to track changes in cardiovascular function by 
monitoring heart rate (HR), and ECG waveforms immediately following telemeter 
implantation, through exposure until 24 hours post-exposure. This methodology provided 
continuous monitoring and collection of physiologic data from individual mice to a remote 
receiver. Sixty-second ECG segments were recorded every 5 minutes during the pre- and 
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post-exposure periods.  ECG was recorded continuously during exposure (baseline and hours 
1-4); HR was automatically obtained from the waveforms (Dataquest ART Software, version 
3.01, Data Sciences International, St. Paul, MN, USA). 
HRV Analysis - Heart rate variability (HRV) was calculated as the mean of the differences 
between sequential RRs for the complete set of ECG waveforms using ECGAuto. For each 
1-min stream of ECG waveforms, mean time between successive QRS complex peaks (RR 
interval), mean HR, and mean HRV-analysis–generated time-domain measures were 
acquired. The time-domain measures included standard deviation of the time between 
normal-to-normal beats (SDNN), and root mean squared of successive differences (RMSSD). 
Analysis of HRV was also conducted in the frequency domain using a fast-Fourier transform. 
For frequency domain analysis, the signal was analyzed with a Hamming window for 
segment lengths of 512 samples with 50% overlapping. The spectral power obtained from 
this transformation represents the total harmonic variability for the frequency range being 
analyzed. In this study, the spectrum was divided into low-frequency (LF) and high-
frequency (HF) regions with frequency bands assigned as 0.15-1.5 and 1.5-5 Hz respectively.  
All ECG streams with less than 1 min of identifiable RR intervals were excluded from HRV 
analysis. Additionally thorough visual inspection was conducted to identify and exclude 
arrhythmias and artifacts.  
Exposure – The study protocol included two days of animal-to-chamber acclimatization 
prior to exposure. 3 hour exposures to both filtered air and acrolein started with 30 min of 
additional chamber acclimatization. Mice served as their own FA control:  They were 
exposed first to filtered air, then exposed to acrolein 24 hours later.  Mice were moved back 
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to their home-cages and monitored immediately following both exposures.  Necropsies were 
performed 24 hours after acrolein exposure. 
Acrolein exposure – Acrolein exposures took place in whole-body plethysmography 
chambers (Model PLY3213, Buxco Electronics, Inc., Wilmington, NC, USA. Acrolein gas 
was metered from a 1,000 ppm cylinder into a glass mixing chamber where the gas was 
mixed and diluted with dry filtered air to achieve a final concentration of 3 ppm of acrolein 
with a total flow of 6 L/min. The actual chamber concentration was measured once per hour 
using an HP5890 gas chromatograph (GMI Inc., Ramsey, MN, USA) equipped with manual 
injection, a flame ionization detector and a DB-VRX capillary column. 
Statistics - All data are expressed as means ± SEM. Statistical analyses of the data were 
performed with GraphPad Prism 6 (GraphPad software, San Diego CA). A minimum power 
of 0.8 was used to determine sample size. For HR, ECG intervals and HRV, two-way 
analysis of variance (ANOVA) for repeated-measures and Bonferroni post hoc tests were 
used to determine statistical differences. A one-way ANOVA was used to analyze arrhythmia 
counts.  Comparisons were made across all groups taking into account the multiple 
endpoints, exposure groups and time points as well as any interactions. 
Statistical Power - We had a sample size of 6, which allows for sufficient power in the 
statistical analysis of various biological/molecular (lung lavage indicators of inflammation 
and toxicity, serum and plasma indicators of coagulation, inflammation, and toxicity, heart 
and lung tissue indicators of inflammation and toxicity, and heart and lung pathology) and 
physiological (electrocardiogram, blood pressure, heart rate, ventilation) endpoints. 
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Results 
Cardiac Responses 
Characterization of HR and HRV in TRPA1 KO vs WT mice - Control WT and TRPA1 
KO mice were injected with saline and exposed to filtered air.  HR and HRV were measured 
during pre-exposure, exposure, and post-exposure time periods (Figure 1.). WT mice 
demonstrated an elevated HR at the beginning of exposure which decreases steadily before 
returning to baseline levels around mid-exposure.  TRPA1 KO mice also had increased HR 
during the first fifteen minutes of exposure, however KO mice demonstrated a more rapid 
return of HR to baseline, producing a statistically significant decrease in HR compared with 
WT mice during early exposure.  Additionally TRPA1 KO mice demonstrated increases in 
SDNN and RMSSD concurrent with their decrease in HR.  There were no other differences 
between the strains for any other measure of HRV or occurrence of arrhythmia 
Effect of pharmacological treatment on HR and HRV in WT and TRPA1 KO mice - 
Treatment with atenolol decreased HR but had no effect on any measure of HRV in WT or 
TRPA1 KO animals.  Treatment with atropine increased HR in both WT and TRPA1 KO 
mice, however this only reached statistical significance in KO mice.  Atropine also 
significantly decreased SDNN in both WT and TRPA1 KO mice.  Treatment with 
hexamethonium slightly decreased HR and SDNN in WT mice but the effect was 
considerably more profound and reached statistical significance only in the TRPA1 KO mice 
(Figure 2).  There was no other pharmacological effects on any measures of HR or HRV in 
either strain (Figure 2. B) 
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Effect of acrolein exposure on HR, HRV and arrhythmia in WT and TRPA1 KO mice - 
Exposure to acrolein produced significant increases in SDNN, RMSSD and LF measures of 
HRV (Figure 3A), as well as an increase in arrhythmia (6.33 ± 2.56) compared with filtered 
air controls (1.33 ± 0.98) and pre-exposure arrhythmia counts (0 ± 0) in WT mice (Figure 
3B).  TRPA1 KO mice did not demonstrate any increases in HRV with exposure to acrolein, 
however there was an increase in arrhythmia (3.66 ± 3.47) compared with pre-exposure 
counts (0 ± 0).  This increase was not significant compared with the TRPA1 KO filtered air 
control group and it was driven by increased arrhythmia from a single animal in the acrolein-
exposed TRPA1 KO group.   
Combined effect of pharmacological treatment and acrolein exposure on HR, HRV and 
arrhythmia in WT and TRPA1 KO mice - Treatment with atenolol blocked acrolein-
induced increases in SDNN and RMSSD but did not affect the acrolein-induced increase in 
LF (Figure 4A and B).  Treatment with atropine enhanced acrolein-induced increases in HR, 
SDNN, RMSSD and LF, and increased HF as well (Figure 4A and C).  Acrolein exposure 
enhanced the decrease in HR observed with hexamethonium treatment alone during early 
exposure.  Treatment with hexamethonium also blunted the acrolein-induced increases in 
SDNN and RMSSD but did not affect the acrolein-induced increase in LF.  Lastly, 
hexamethonium treatment increased HF during the final half hour of exposure (Figure 4A 
and D).  Treatment with all three pharmacological agents blocked the acrolein-induced 
increase in arrhythmia (Figure 5). 
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Ventilatory Responses 
Characterization of ventilatory timing in TRPA1 KO vs WT mice - Control WT and 
TRPA1 KO mice were injected with saline and exposed to filtered air. Ventilatory 
parameters were measured during exposure (Figure 6).  Compared with WT mice TRPA1 
KO mice demonstrated increased inspiratory and expiratory time periods, as well as 
decreased breathing frequency.  TRPA1 KO mice also demonstrated increased enhanced 
pause values throughout the exposure but only reaching statistical significance during the 
final hour. 
Effect of acrolein exposure on ventilation in WT and TRPA1 KO mice - Exposure to 
acrolein produced changes in measures of ventilatory timing (Figure 7A) as well as 
qualitative differences in the shape and amplitude of the ventilatory flow trace (Figure 7B) in 
WT mice.   TRPA1 KO mice did not demonstrate any changes in ventilatory timing with 
exposure to acrolein with the exception of an increase in enhanced pause during the final 15 
minutes of exposure (Figure 7A and C).  
Effect of pharmacological treatment on ventilation in WT and TRPA1 KO mice - WT 
and TRPA1 KO mice did not produce significant responses to atenolol or atropine treatment 
alone.  Hexamethonium treatment however produced minor changes in ventilatory timing in 
KO mice; namely an early decrease in inspiratory and expiratory time as well as a decrease in 
breathing frequency and minute volume. 
Combined effect of pharmacological treatment and acrolein exposure on ventilation in 
WT and TRPA1 KO mice - In WT mice treatment with atenolol blunted the acrolein-
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induced changes in ventilatory timing, including blocking the increase in expiratory time and 
decrease in breathing frequency.  Atenolol treatment with acrolein also attenuated the 
acrolein-induced increase in peak expiratory flow and reduced relaxation time (Figure 8A 
and B).  Treatment with atropine also blunted the acrolein-induced changes in ventilatory 
timing including blocking the decrease in breathing frequency, as well as attenuating the 
acrolein-induced increases in expiratory time and tidal volume. Atropine treatment also 
decreased relaxation time during early exposure (Figure 8A and C).  Hexamethonium 
treatment produced a biphasic response where inspiration time, expiration time and 
relaxation time were only increased during early exposure, while peak expiratory flow, tidal 
volume and enhanced pause were reduced at the earliest time points but quickly rose within 
the first hour and remained elevated.  Hexamethonium treatment also reduced breathing 
frequency during early exposure and elevated it during late exposure (Figure 8A and D). 
TRPA1 animals exposed to acrolein demonstrated an increase in enhanced pause only during 
the final fifteen minutes of exposure; this was blocked by treatment with atropine (Table#). 
Biochemical markers and inflammatory cells in BAL - Biochemical analysis of BAL fluid 
showed that TRPA1 KO mice had lower SODtotal as well as MnSOD compared with WT 
mice. Treatment with atropine and atenolol blocked this effect.  There were no other 
significant differences between any other groups. 
Discussion 
 Building on our previous findings, this study demonstrates that TRPA1 mediates 
acrolein-induced cardiovascular changes through mechanisms involving both the 
parasympathetic and sympathetic branches of the autonomic nervous system. In addition, 
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TRPA1 also plays a role in acute breathing changes indicative of airway irritation in these 
healthy mice. Although, one of the proposed pathways for the cardiovascular effects of air 
pollution includes the activation of irritant reflex arcs and modulation of autonomic function 
there has been very little data characterizing this phenomenon to date. Part of the challenge 
of clarifying these mechanisms has been due to the complexity of autonomic cardiovascular 
control from a systemic perspective; namely, the fact that it is governed by several regulatory 
processes whose interplay can vary on a beat-to-beat basis. In particular, the body is 
continuously monitored by internal sensory apparatuses (i.e. baro- and chemosensory) that 
send information to the parasympathetic and sympathetic branches which in turn alter the 
activity of the heart and vasculature. The regular beating of the heart is also modulated in this 
manner by external “sensors” which respond to environmental stimuli by activating 
cardiopulmonary reflex arcs upon exposure and reseting autonomic function and control of 
the heart for a certain amount of time thereafter (Perez et al. 2015). Although these data 
demonstrate how autonomic nervous system function is modulated by exposure to inhaled 
irritants to produce reflexive changes in not only ventilatory function, but cardiovascular 
function as well, they certainly do not address all the possible mechanisms underlying these 
effects.  
 We previously demonstrated that TRPA1 mediates increased HRV and incidence of 
arrhythmia during exposure to acrolein (Chapter II). These results were reproduced in the 
current study in which we observed increased SDNN, RMSSD and LF measures of HRV, as 
well as an increase in brady-arrhythmias with exposure to acrolein which were not apparent 
in the TRPA1 KO animals. Overall, these data suggested that the response to acrolein, which 
is a ubiquitous air pollutant and activator of TRPA1, was characterized solely by 
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parasympathetic dominance. However cardiac and ventilatory responses during exposure to 
acrolein following pharmacological blockade of one or both branches of the autonomic 
nervous system demonstrated a role for both sympathetic and parasympathetic modulation. 
Atenolol, which blocks β1-adrenergic receptors and ostensibly sympathetic 
neurotransmission at the level of the heart, significantly reduced both the time-domain HRV 
response to acrolein exposure, whereas atropine, which prevents parasympathetic 
neurotransmission by blocking muscarinic receptors on the heart, enhanced all of the 
acrolein-induced HRV responses and in particular increased HF which was not evident in 
animals without pharmacological blockade. Thus, even though an increase in HRV, 
specifically RMSSD and HF, generally reflects parasympathetic modulation, sympathetic 
effects also appear to play a role.  
 As such, the response of un-exposed mice to the pharmacological drugs might help to 
clarify what is happening during exposure. Blockade of parasympathetic, sympathetic or both 
confirmed two things in general: (1) baseline heart rate in mice is greatly influenced by the 
sympathetic branch, hence the significant reduction in heart rate with atenolol and similar 
trend with hexamethonium, and minimal effect with atropine, and (2) although short-term 
HRV is under the control of both branches it is mostly regulated by parasympathetic 
modulation (Gehrmann et al. 2000; Pham et al. 2009); this could be seen by the atropine-
induced decrease in SDNN and similar trend in RMSSD and LF, and lack of effect of 
atenolol on any HRV parameter. These characteristics need to be carefully considered when 
assessing the HRV effects of acrolein exposure, particularly when combined with 
pharmacological blockade.  
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 The entire 3-hour exposure to acrolein appears to produce a bi-phasic response 
characterized by early sympathetic modulation followed by enhanced vagal modulation at 
later time-points. The fact that we observed an early elevated heart rate in air-exposed mice 
as well as in those exposed to acrolein suggests that a generalized stress response, one 
potentially due to handling, injection and placement in the exposure chamber, may have 
contributed to the sympathetic modulation early during the exposure. This appears to be 
unresolvable, even with acclimatization (Andreev-Andrievskiy et al. 2014). However, 
midway through the exposure, acrolein appears to prevent the decline in heart rate, albeit 
without further increase, when compared to air, an effect which coincides with a significant 
increase in SDNN, RMSSD and LF. Thus, this time point likely represents the period of 
acrolein effects without the generalized stress. Furthermore, it is apparent from our 
pharmacological treatment approach (i.e. immediately prior to acrolein exposure) that most 
of the physiological effects of the drugs occurred within the first half of the exposure period 
and so what was observed in the second half of the exposure was a rebound response to the 
dissipation of the drug effect. This physiological “compensation” when the drug washes out 
has been reported by others (Fuder & Muscholl 1995; Farah et al. 2006) and in our case 
likely contributes to blocking the HRV effects of acrolein. 
 It is notable that during the first half of the exposure, atenolol blocked the generalized 
stress-induced increase in HR and likely prevented any blood pressure increases as well. On 
the other hand, atenolol does not block the stress-induced increased sympathetic nerve 
activity given it blocks neurotransmission at the level of the heart. Thus, increased 
sympathetic nerve activity would continue to inhibit acetylcholine release from 
parasympathetic nerves keeping SDNN and RMSSD low. Once again, this has been observed 
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with other models of stress in the same strain of mice (Andreev-Andrievskiy et al. 2014; 
Fuder & Muscholl 1995; Farah et al. 2006). As far as the second half of the exposure is 
concerned, atenolol’s ability to block the acrolein-induced SDNN/RMSSD increase may be 
due to the recovery of sympathetic influence on the heart as the drug washes out which 
ostensibly balanced out the increased parasympathetic shift which occurred due to irritant 
inhalation (Farraj et al. 2015; Carll et al. 2015; Hazari et al. 2014). To some degree this is 
likely related to baroreflex on autonomic balance, since the atenolol-induced effects in the 
first half of exposure likely result in reflex sympathetic activation later (Just et al. 2000).  
 The aforementioned conclusion is also supported by the fact that cholinergic blockade 
with atropine resulted in a further increase in heart rate and decrease in SDNN and RMSSD 
in the first half of acrolein exposure. These results are in accordance with the concept that the 
cardiac stress response in mice is due to activation of sympathetic and withdrawal of 
parasympathetic activity. This also reiterates the point that HRV in mice is dominated by 
parasympathetic tone especially when considered with atenolol’s lack of SDNN and RMSSD 
effects. Subsequently, as atropine washed out in the second half of the exposure, recovery of 
parasympathetic influence further increased SDNN, RMSSD and even the frequency domain 
measures. In fact, the increase in LF during the second half of exposure, which was not 
blocked by any treatment, may in part represent the respective recovery of sympathetic and 
parasympathetic influence with atenolol and atropine treatment. This is a reasonable assertion 
given LF indicates not only sympathetic and parasympathetic modulation but baroreflex 
input as well (Reyes del Paso et al. 2013).  
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 Hexamethonium blocks both braches of the autonomic nervous system and this 
appears to reduce the acrolein-induced HRV response overall, however there is still some 
effect of exposure confirming that parasympathetic activity dominates mouse HRV and 
indicating homeostatic control mechanisms which function outside of direct autonomic 
modulation of heart rate but still contribute to HRV measures (Sayers 1973; Parati et al. 
1995). Additional control mechanisms include baroreflex but also respiratory sinus 
arrhythmia (i.e. breathing patterns), which can also drive changes in HRV (Sayers 1973; 
Reyes del Paso et al. 2013). In fact, early work on upper airway irritants such as acrolein 
suggested a biphasic response to irritants such as acrolein whereby there is early sympathetic 
modulation followed by a parasympathetic dominance (Alarie 1973).  It is this later vagal 
dominance phase that is being suppressed by atenolol and enhanced by atropine as detailed 
above.   
 Exposure to acrolein produced an increase in arrhythmia in WT animals, however the 
total number of arrhythmia identified was very low with a group average 6.3 ± 2.5 
occurances over the entire 3 hour exposure period. It is notable that 4 of the 6 animals in the 
WT group were responders, however mild, while apparent increases in arrhythmia occurring 
in the KO animals were driven by a single animal. This result did reach statistical 
significance, and may represent a slight arrhythmia response to acrolein exposure, 
nevertheless the physiological significance of this finding is questionable.  
 In an effort to characterize the effect of acrolein on breathing patterns, ventilatory 
parameters were also measured during exposure using whole-body plethysmography. 
Exposure to acrolein produced striking changes in the quality and rhythm of ventilation in 
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WT mice but not TRPA1 mice. The primary changes observed in the ventilatory parameters 
such as decrease in respiratory rate, increased expiratory pause and peak expiratory time, 
increased tidal volume, and increased enhanced pause or ventilatory timing are all hallmarks 
of an upper airway irritant response which is mediated by stimulation of the trigeminal nerve 
(Alarie 1973; Morris et al. 2003; Vijayaraghavan et al. 1993). The decrease in respiratory 
rate and elongated expiratory phase specifically are linked with the phenomena of ventilatory 
“braking” whereby reflexive glottal closure and inhibition of the phrenic nerve impair 
expiratory flow at the onset of expiration” (Alarie, 1973; Vijayaraghavan et al., 1993). The 
results presented here corroborate the findings of others (Bessac & Jordt 2008) that TRPA1 
mediates these responses. Interestingly, pharmacological blockade with atenolol and atropine 
generally only blocked the ventilatory changes related to frequency and tidal volume whereas 
enhanced pause remained elevated. On the other hand, hexamethonium worsened the 
acrolein-induced changes in frequency and tidal volume. Although the role of the autonomic 
branches in these ventilatory effects is unclear, it appears the activity of one or the other is 
necessary to maintain normal breathing. Yet, any effects observed due to the 
pharmacological drugs may also be secondary to the cardiovascular changes. Further work 
connecting irritant ventilatory responses to cardiovascular changes is needed in order for us 
to understand this better.  
 At baseline WT and TRPA1 KO mice demonstrate differences in cardiac and 
ventilatory function.  Control saline-injected mice exposed to filtered air produce a 
sympathetically mediated stress response to being handled and injected, one indicator of this 
was an increase in heart rate in both strains of mouse at the earliest exposure time points. 
TRPA1 KO mice HR’s returned to baseline much more quickly than WT mice.  This fast 
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decrease in HR occurred simultaneously with increases in HRV indicating enhanced cardiac 
parasympathetic modulation (Stein et al. 1994).  TRPA1 KO mice also responded more 
robustly to pharmacological agents blocking cardiac parasympathetic neurotransmission than 
WT mice. Lastly, control TRPA1 KO mice demonstrated decreased inspiratory and 
expiratory times as well as decreased breathing frequency during exposure compared with 
WT mice. Overall the TRAP1 KO mice demonstrated a calmer phenotype than the WT mice 
characterized by a quicker return to baseline HR after stress and slower breathing, both of 
which are likely mediated through a baseline elevation in parasympathetic modulation.   
Considering the baseline differences in HRV between the WT and TRPA1 KO mice, direct 
comparisons across strains may not be valuable.  Inter strain comparisons of exposure and 
pharmacological effect however should be valid. In addition, there are a number of other 
elements in this study which contribute to the difficulty/complexity in analyzing the results. 
Chief of which is that the temporal natures of the stress response, the exposure response and 
the pharmacodynamics of the agents used to block cardiac autonomic neurotransmission 
were not fully considered, or understood, until after the completion of this study.  In 
retrospect it may have been beneficial to allow the animals to acclimate in the chamber, 
begin exposure and then infuse the pharmacological agents (rather than rely on a single 
injection immediately prior to exposure).  In this way the stress response, exposure response 
and pharmacological interventions would have been parsed in to distinct stages rather than 
overlaid on top of each other.   
 Taken together these data indicate TRPA1 as a mediator of the cardiac response to 
airway irritants via autonomic modulation.  This response is likely centrally-driven rather 
than being mediated through local release of neuropeptides.  The cardiac effects we observed 
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were driven by changes in both branches of the autonomic nervous system, with a stress 
response producing sympathetic modulation and airway irritation producing parasympathetic 
modulation. With prolonged exposure there is the potential for compensatory effects as one 
branch is activated, dominates, and then turns off, the other branch may rebound.   
 These data demonstrate that exposure to air pollution can disrupt normal autonomic 
balance in healthy young animals, producing marked changes in both cardiac and ventilatory 
function.  Both the sympathetic and parasympathetic branches of the autonomic nervous 
system appear to play a role in the physiological responses observed, likely in a biphasic 
manner characterized by early sympathetic activation followed by a prolonged period of 
vagal dominance. This study highlights the inextricable link between the cardiac and 
pulmonary systems, and begins to describe how a complex interplay between sympathetic 
and parasympathetic arms of the autonomic nervous system may modulate their function 
during exposure to air pollution.  The increase in risk inherent to autonomic imbalance is not 
obvious.  Rather these changes represent a latent risk; a loss of compensatory capacity in the 
animal, which may predispose them to adverse cardiovascular events only when challenged.  
This type of risk is particularly pronounced in susceptible sub-populations; those with 
already impaired compensatory capacity such as people with underlying cardiac or 
respiratory disease.   
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Tables and Figures 
Table 1. Summary of acrolein exposure and pharmacological treatment effects on measures 
of HRV and occurrence of arrhythmia in WT and TRPA1 KO mice
 
Compared with filtered air-exposed controls 
 
Table 2. Summary of acrolein exposure and pharmacological treatment on ventilatory 
parameters in WT and TRPA1 KO mice.  
 
Compared with filtered air-exposed controls 
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Figure 1.TRPA1 KO mice demonstrate altered cardiac autonomic modulation compared 
with WT mice.  HR, SDNN and RMSSD measurements during pre-exposure period (-24hr), 
exposure (1-3hr), immediately post-exposure (6hr), and one day post-exposure (24hr).  Data 
are from saline-injected, filtered air-exposed control animas, both WT and TRPA1 KO. Data 
points are mean ± SEM.*p ≤ 0.05; significantly different from WT mice (n=6) 
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Figure 2. WT and TRPA1 KO mice respond similarly and predictably to pharmacological 
agents affecting autonomic nervous system function. A. HR and SDNN measurements during 
pre-exposure period (-24hr), exposure (1-3hr), immediately post-exposure (6hr), and one day 
post-exposure (24hr).  Data are from saline or drug-injected, filtered air-exposed animas; 
both WT and TRPA1 KO. Data points are mean ± SEM. †p ≤ 0.05; significantly different 
from saline-injected controls (n=6). B. Summary of pharmacological treatment effects on 
measures of HRV in WT and TRPA1 KO mice compared with saline-injected controls. 
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Figure 3. TRPA1 mediates acrolein-induced increases in HRV and arrhythmia.  HR and 
HRV measurements during pre-exposure period (-24hr), exposure (1-3hr), immediately post-
exposure (6hr), and one day post-exposure (24hr).  Saline-injected, filtered air or acrolein-
exposed animas; both WT and TRPA1 KO. Data points are mean ± SEM. B. Total 
arrhythmia counts during a time-matched pre-exposure period (Pre-exp), exposure (Exp), a 
post-exposure period immediately following exposure (Post-exp), and a time-matched post-
exposure period one day later (24hr Post-exp). All exposure periods were 3 hours in duration. 
Individual data points per group are plotted and “+” indicates group mean.  C. Summary of 
acrolein exposure effects on measures of HRV and arrhythmia in WT and TRPA1 KO mice 
compared with filtered air-exposed controls. *p≤ 0.05; significantly different from filtered 
air-exposed controls (n=6). ‡p≤0.05; significantly different from Pre-exp 
A. 
B. 
C. 
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Figure 4. Pharmacological treatments affecting cardiac autonomic modulation alter the HR 
and HRV response to acrolein exposure. HR and HRV measurements in WT animals 
exposed to filtered air or acrolein and treated with saline or one of three pharmacological 
agents affecting cardiac autonomic function. Atenolol blocks sympathetic neurotransmission 
in the heart. Atropine blocks parasympathetic neurotransmission in the heart. 
Hexamethonium blocks both sympathetic and parasympathetic peripheral neurotransmission. 
Exposure periods are defined as follows: pre-exposure period (-24hr), exposure (1-3hr), 
immediately post-exposure (6hr), and one day post-exposure (24hr). Data points are mean ± 
SEM. *p ≤ 0.05; significantly different from filtered air-exposed controls (n=6). †p≤0.05; 
significantly different from saline-treated controls.  
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Figure 5. Pharmacological treatments affecting cardiac autonomic modulation prevent 
acrolein-induced increases in arrhythmia in WT mice. Total arrhythmia counts during a time-
matched pre-exposure period (Pre-exp), exposure (Exp), a post-exposure period immediately 
following exposure (Post-exp), and a time-matched post-exposure period one day later (24hr 
Post-exp). All exposure periods were 3 hours in duration. “+” indicates group mean. *p ≤ 
0.05; significantly different from filtered air-exposed controls (n=6). 
 
 
Figure 6. TRPA1 KO mice demonstrate altered ventilatory timing compared with WT mice.  
Ti, Te, breathing frequency and enhanced pause during exposure period.  Data are from 
saline-injected, filtered air-exposed control animas, both WT and TRPA1 KO. Data points 
are mean ± SEM.*p ≤ 0.05; significantly different from WT mice (n=6) 
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Figure 7. TRPA1 mediates acrolein-induced changes in ventilatory timing.  Data are from 
saline-injected, filtered air or acrolein-exposed animas; both WT and TRPA1 KO. Data 
points are mean ± SEM. B. Representative traces from saline-injected control animals 
exposed to either filtered air or acrolein demonstrating ventilatory “braking” in response to 
acrolein exposure. C. Summary of ventilatory response to acrolein exposure in WT and 
TRPA1 KO mice compared with filtered air-exposed controls. *p ≤ 0.05; significantly 
different from filtered air-exposed controls (n=6). 
A
. 
B
. 
C
. 
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Figure 8. Pharmacological treatments affecting cardiac autonomic modulation alter the 
ventilatory response to acrolein exposure.  Ventilatory parameters during exposure.  WT 
animals exposed to filtered air or acrolein and treated with saline or one of three agents 
affecting cardiac autonomic function. Atenolol blocks sympathetic neurotransmission in the 
heart. Atropine blocks parasympathetic neurotransmission in the heart. Hexamethonium 
blocks both. Data points are mean ± SEM. *p ≤ 0.05; significantly different from filtered air-
exposed controls (n=6). †p≤0.05; significantly different from saline-treated control
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CHAPTER V: CONCLUSIONS AND IMPLICATIONS 
 Early air pollution regulations were focused on reducing emissions and ambient air 
pollution levels in order to decrease the risk of large-scale public health emergencies due to 
sudden extreme events such as the ones in London and Donora, PA in the mid-20th century.  
Over the past 50 years ambient air pollution levels have been significantly reduced.  
However 60 million people in the U.S. still lives in areas that meet or exceed at least one 
NAAQS (U.S. EPA n.d.).  Additionally, the public health impact of ambient air pollution still 
remains significant, producing an estimated 200,000 additional deaths each year in the US 
(Fann et al. 2013).  There is also a growing rate of chronic diseases, especially cardiovascular 
disease, in the United States.  In fact, a report from the American Heart Association estimates 
that by 2030 ~40% of the US population will have some form of cardiovascular disease 
(Heidenreich et al. 2011).  Thus a large segment of the population has a heightened risk of 
adverse health effects due to environmental exposure and should be treated as a susceptible 
sub-group.  Future regulatory decisions need to consider these susceptible populations.  
Research presented in this dissertation, exploring the health effects of low level or acute 
exposures, exposures to pollutant mixtures, and elucidation of the specific mechanisms 
underlying the increased risk for adverse cardiovascular events in both normal and 
susceptible populations will contribute greatly to these regulatory decisions and aid in the 
identification of air pollution levels which produce no observable adverse effect
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 Susceptibility is defined as “the state of being likely or liable to be influenced or 
harmed by a particular thing.”(Oxford Online 2010).  In the case of air pollution-induced 
adverse cardiovascular events, susceptibility usually refers to the presence of existing disease 
or other conditions which predispose a person to deleterious effect and allows for the 
development of decrements in cardiovascular function over time.  Other factors known to 
contribute to air pollution-induced cardiovascular susceptibility include genetic 
polymorphisms (Yang et al. 2009; Kleeberger 2003) and life stage (Mead 2011).  
Socioeconomic status, which encompasses a variety of additional modifiable factors 
including nutritional status and body mass index, social stressors, and access to healthcare, 
also contributes to the overall health state of the individual, which could in turn modify their 
response to air pollution (Clougherty & Kubzansky 2009; Schwartz et al. 2011).  Thus, 
susceptibility to air pollution-induced cardiotoxicity in terms of pre-existing conditions 
describes an organism already existing in a state of homeostatic imbalance, where further 
challenge by air pollution may then shift the organism past the bounds of their compensatory 
capacity and produce cardiovascular dysfunction. The key challenge exists in measuring 
these conditions such that an accurate picture of the existing risk can be determined. 
 Methodologies employed in the detection of early physiological and biochemical 
changes have rapidly advanced in the past few decades alone.  As such we are now able to 
detect changes in physiological and biochemical function which in fact precede the 
development of symptoms related to injury or disease (Bates 2005).  We have progressed 
well beyond mortality as a primary indicator of the effects of air pollution on a population, 
and now have the tools to effectively identify the level, if any, at which air pollution is no 
longer producing any adverse effects. In the least, we have become keenly aware of the fact 
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that not all the toxicological effects of air pollution are overt or clinical but rather more than 
likely occur latently in most people. Understanding the mechanisms underlying air-pollution 
induced cardiovascular toxicity allows for the potential development of interventions, but 
more importantly contributes to the identification of sensitive sup-populations who are more 
susceptible to air-pollution induced injury due genetic background, existing injury, disease 
state, or the influence of other environmental factors such as diet or general stress level. 
 The research described here was conducted to investigate previously undescribed 
toxicological mechanisms underlying adverse cardiovascular events associated with acute air 
pollution exposure. As such, the basis for this work was predicated on a wealth of 
epidemiological studies showing that exposure to air pollution causes increased 
cardiovascular morbidity and mortality. In particular, large-scale studies have shown that air 
pollution causes changes in heart rate variability, which although derived from heart rate, 
signifies subtle shifts in the internal autonomic controls of the body and a potential increase 
in cardiovascular risk. These autonomic controls are regulated by an intricate network of 
neural sensors, which monitor not only the normal physiological function of the body (e.g. 
blood pressure) but also external exposure to potentially harmful environmental substances. 
Yet the effects that result from changes to these components are not necessarily overt and 
often lack a simultaneous relevant clinical symptom that points to the health threat. Thus, the 
underlying assumption is a change in heart rate variability reflects a state of homeostatic 
imbalance, where further stress on the body may shift the body past the bounds of its 
compensatory capacity and produce cardiovascular dysfunction. There are numerous clinical 
and experimental data that demonstrate autonomic imbalance plays a role in the adverse 
cardiovascular effects of acute air pollution exposure (Davoodi et al. 2010; Link & Dockery 
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2010; Hazari et al. 2011). However, to date, there are very few studies that have specifically 
characterized the neural link between the targeting of the respiratory system by air pollution 
and altered autonomic control of the cardiovascular system. Consequently, several studies 
have shown that the initiating event for a certain class of inhaled irritants, several of which 
are found in complex air pollution mixtures, is the activation of TRPA1 and subsequent 
signaling through the central nervous system. 
 This dissertation explores the hypothesis that TRPA1 mediates air pollution induced 
autonomic imbalance and cardiac dysfunction (Figure 1.2).  To this end, cardiac responses to 
air pollution exposure, both electrical and mechanical, were characterized in the wild-type 
mouse.  Then TRPA1 knockout mice were incorporated into subsequent studies to determine 
1) what role if any TRPA1 plays in the mediation of air pollution induced cardiac 
dysfunction 2) whether autonomic changes are associated with adverse cardiac effects, and 3) 
how exactly autonomic nervous system function is modulated by exposure to inhaled irritants 
to produce cardiac effects.  These data describe mechanisms underlying cardiovascular 
toxicity associated with acute exposure to air pollution, and aid in the identification of 
potentially sensitive subpopulations and periods of heightened risk. Taken together these 
results contribute to the assessment of risk to public health due to air pollution exposure, not 
only among sensitive groups but among the seemingly healthy as well.  
 
Principal Conclusions 
Exposure to particulate and gaseous air pollution produces electrocardiogram and 
mechanical responses in the mouse heart - Exposure to common constituents of air 
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pollution produce decrements in cardiac electrical and mechanical function in the mouse 
heart similar to those observed in humans including arrhythmia (Peters et al. 2000). Although 
PM has long been the focus of most epidemiological and experimental air pollution research 
and has been associated with myocardial infarction, stroke, arrhythmia, and exacerbation of 
heart failure (Brook et al. 2010), air pollution is a complex mixture with volatile gaseous 
components as well. Furthermore, the majority of ambient air pollution by mass is in the 
gaseous or vapor phase (Brook et al. 2010).  Ozone, which along with PM is another 
ubiquitous pollutant, has been associated with decreased HR, alteration of cardiac 
repolarization and increased inflammation (Farraj et al. 2012; McIntosh-Kastrinsky et al.; 
Balmes et al. 2011). Therefore research needs to examine the combined effects of PM and 
ozone, particularly to clarify where the interactions are synergistic, antagonistic or additive. 
We found disparate effects between size-fractionated PM with fine CAPs altering autonomic 
balance and ultrafine CAPs increasing the incidence of cardiac arrhythmia and producing 
decrements in left ventricular mechanical function.  These effects were only apparent in 
ozone co-exposed animals, suggesting that ozone interactions contribute to the 
cardiovascular response to PM, however the results suggest that it is not generalizable to the 
particle size modes.  Previous work examining PM and ozone co-exposure primarily focused 
on pulmonary inflammation endpoints (Bouthillier et al. 1998; Farraj et al. 2010; Vincent et 
al. 1997; Kumarathasan et al. 2015) and did not examine cardiovascular function. Thus, this 
study fills an existing gap in the research describing how ozone may contribute to or 
otherwise modify the cardiovascular response to PM inhalation. O3 may have enhanced the 
response to PM via direct interaction with airway tissues producing damage and oxidative 
stress, additionally ozone may have interacted with PM constituents forming potent reactive 
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species and indirectly contributed to oxidative stress and enhancing the PM effect.  
Furthermore, the size fraction of PM is a major determinant in the location of airway 
deposition (i.e. pulmonary vs extra-thoracic), and sub-types of airway sensory receptors 
impacted, all of which may contribute to the disparate responses observed between 
particulate modes. Finally, the fact that these latent effects were observed in the absence of 
overt toxicity at very low ambient concentrations demonstrates the subtle homeostatic 
changes that can occur as a result of air pollution exposure. 
 
TRPA1 mediates changes in heart rate variability and arrhythmia following exposure to 
acrolein - TRPA1 has been previously described as an airway irritant sensor which is known 
to mediate some reflexive respiratory responses to air pollution exposure, particularly certain 
highly-reactive noxious compounds (Bessac & Jordt 2008).  It has also been suggested that 
TRPA1 may act as a direct target of many constituents of air pollution including components 
of wood smoke (Shapiro et al. 2013) and diesel exhaust (Deering-Rice et al. 2011), heavy 
metals including zinc, cadmium and copper (Hu et al. 2009; Gu & Lin 2010), as well as 
gaseous air pollutants ozone (Taylor-Clark & Undem 2010), and acrolein (Andrè et al. 2008; 
Hinman et al. 2006).  The majority of this research has been done in-vitro or utilized isolated 
organ perfusion systems. While these techniques provide a great deal of insight regarding 
channel activation and elucidation of the neural pathways potentially involved in the adverse 
cardiopulmonary response, physiological endpoints in the whole organism can only be 
inferred. The adverse effects ascribed to air pollution exposure result from the interplay of 
responses across multiple organ systems, with deficits in one organ system affecting the 
others.  Thus, it is necessary that whole animals were used in these studies.  I measured 
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physiological endpoints, relevant to the development of serious cardiovascular events, such 
as arrhythmia, along with more subtle alterations in autonomic and mechanical function. Our 
previous studies in rats demonstrated that pharmacological inhibition of TRPA1 attenuated 
air pollution-induced cardiac arrhythmia (Hazari et al. 2011).  This study, using both 
C57BL/6 wild-type and TRPA1 knockout mice demonstrated that acrolein produced 
autonomic imbalance and an increased incidence of arrhythmia through TRPA1, which also 
mediated an increase in LVDP. In contrast, exposure to ozone did not appear to cause any 
significant effects despite the fact that mild cardiovascular effects of ozone at similar levels 
have been documented by our lab in the past and by others (Wu et al. 2010; Farraj et al. 
2012; Barath et al. 2013; Wang et al. 2013; Kurhanewicz et al. 2014; Farraj et al. 2015).  
This result highlights the fact that the cardiovascular response to near-ambient ozone 
exposure in-vivo is variable and warrants further study.  With this work we have 
demonstrated that autonomic nervous system function can be modulated by airway TRPA1 
activity, and appears to also play a role in acrolein-induced cardiac arrhythmia and 
mechanical changes. A likely mechanism linking airway irritation and cardiac dysrhythmia is 
the activation of C-fibers which triggers the release of centrally-acting neurotransmitters 
including glutamate and substance P in the NTS.  This process is known to modify 
autonomic regulation of cardiac and respiratory function(Mutoh, Bonham, et al. 2000; 
Bonham et al. 2001).  Similar mechanisms have already been demonstrated in models of 
cigarette smoke irritation (Mutoh, Joad, et al. 2000) as well as others (Paton & Nolan 2000; 
Simms et al. 2006), while TRPA1’s role in modulating other “autonomic” activity (e.g. 
breathing) in the brainstem is also known (Tani et al. 2015).  This is the first study however 
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to directly demonstrate a role for airway TRPA1 in mediating autonomic imbalance and 
changes in cardiac function due to air pollution.  
 
Exposure to acrolein produces changes in heart rate variability and increased incidence of 
arrhythmia indicative of increased vagal modulation, however sympathetic modulation 
also plays a role. - In our studies, increased HRV, and therefore parasympathetic modulation, 
was observed with an increased incidence of sinus node dysfunction and bradyarrhythmia 
during acrolein exposure in normal animals.  Unlike respiratory sinus arrhythmia, which 
occurs regularly/periodically according to cyclic ventilatory patterns, these acrolein-induced 
arrhythmias occurred randomly albeit with increasing frequency through the course of 
exposure. Increased vagal tone is known to produce changes in the P-wave to P-wave 
interval in the electrocardiogram independent of normal breathing. This condition is known 
as non-respiratory sinus arrhythmia and it differs from respiratory sinus arrhythmia (RSA) in 
that it is not associated with respiration but rather occurs when the outflow of 
parasympathetic tone predominates over sympathetic tone (Deboor et al. 2005; McMullen et 
al. 2012). In humans, intermittent periods of bradycardia, and bradyarrhythmia indicating 
sinus node dysfunction along with parasympathetic dominance are all features included in a 
group of abnormal heart rhythms termed sick sinus syndrome (Keller & Lemberg 2006).  It is 
interesting that acrolein exposure produces comparable effects in the mouse.  While this does 
not indicate the development of sick sinus syndrome in acrolein exposed individuals per se, it 
does highlight the underlying feature of autonomic imbalance and strengthen the case for 
plausibility of this mechanism in humans as well as mice.  Alterations from baseline HRV, 
both increases and decreases, have been implicated in the development of adverse 
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cardiovascular events indicating that any change in autonomic function which shifts the 
animal out of homeostatic balance represents an increase in risk due to impaired 
compensatory capacity to respond to subsequent challenges or stressors.  These effects would 
be all the more apparent in populations with existing impairments in compensatory capacity 
(e.g. susceptible individuals such as those with underlying cardiovascular disease) 
 On the whole these results suggest that the autonomic response to acrolein is 
characterized solely by parasympathetic dominance. However cardiac responses during 
exposure to acrolein following pharmacological blockade of one or both branches of the 
autonomic nervous system demonstrated a role for both sympathetic and parasympathetic 
modulation. Sympathetic neurotransmission blockade by atenolol reduced the HRV response 
to acrolein, while parasympathetic neurotransmission blockade by atropine enhanced HRV 
response to acrolein overall. There is limited existing research examining exactly how 
functional changes in autonomic nervous system function results in specific changes in 
measures of HRV, especially with regard to air pollution exposure done using whole animals.  
As such, this research adds a wealth of new data that better characterizes autonomic 
imbalance as a risk factor for cardiac dysfunction in air pollution exposures (Figure 1).   
  In general, when addressing the cardiovascular effects of air pollution, further 
exploration is needed addressing factors contributing to HRV such as breathing patterns, 
stimuli-driven changes in blood pressure, and the effects of modifying factors like as 
nutritional status.  Additionally, research focusing on common components of air pollution 
and their individual contributions to the types of autonomic and cardiovascular responses 
described herein would be valuable for informing the public about specific risks inherent to 
specific varieties of air pollution (e.g. high PM days vs high oxidant days)                                                                         
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Summary and Broad Perspectives on Findings 
 This research helps to improve our current understanding of the effects of air 
pollution on cardiovascular health. All of the studies described herein used healthy, young to 
middle aged mice, with no known co-morbidities.  That adverse cardiovascular responses, 
however subtle, could be elicited in these cohorts following a single acute exposure to 
common air pollutants is not trivial as it implies that while epidemiological studies have 
demonstrated populations with underlying cardiovascular and pulmonary diseases represent 
the most sensitive group, nobody is completely protected from potentially adverse 
homeostatic shifts toward increased risk for adverse cardiovascular events following 
exposure to air pollution (Figure 1), particularly when the components include airway 
irritants like acrolein.  
 Figure 1. Autonomic Imbalance Shifts the Individual Toward an Increased 
Risk for Adverse Cardiac Events 
 
 This project contributes to the scientific literature addressing the mechanisms 
underlying the association between exposure to air pollution and cardiovascular dysfunction 
and confirms the utility of animal models in extrapolating human responses. As such, we 
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demonstrate that mice produce similar decrements in cardiac electrical and mechanical 
function as humans following exposure to air pollution and that reflexive cardiovascular 
responses to airway irritants in particular are mediated by TRPA1, a mechanism which is 
likely similar in humans. In addition, while the cardiovascular response to airway irritants 
appears to be characterized primarily by enhanced vagal modulation, sympathetic nervous 
system activity also plays a role (Figure 2).  These novel findings support and extend 
important information regarding mechanisms by which airway irritant exposure results in 
adverse health effects and provides a tangible piece of evidence that can be used for applied 
purposes like risk assessment and potentially the setting of standards. With heart disease as 
the number one cause of death worldwide, understanding these contributing factors paves the 
way for the development of interventions, or may help shape future regulatory measures, 
which could produce drastic public health benefits. 
Figure 2. Cardiac Dysfunction Following a Single Acute Exposure to Air Pollution is the 
Result of Altered Autonomic Nervous System Function, which is Mediated by TRPA1 
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